Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 516
interventional 444
Observational 69
Registry 3

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 147
Drug|placebo 143
Behavioral 39
Other 30
Device 17
Behavioral|Drug 14
Behavioral|Other 12
Dietary Supplement|placebo 9
Dietary Supplement 7
Behavioral|Drug|placebo 4
Drug|Other 3
Behavioral|Drug|Other 2
Dietary Supplement|Drug 2
Dietary Supplement|Other 2
Other|placebo 2
Behavioral|Device 1
Behavioral|Device|Other 1
Behavioral|Dietary Supplement 1
Behavioral|Dietary Supplement|Other 1
Behavioral|Drug|Other|placebo 1
Device|Drug 1
Diagnostic Test 1
Drug|Other|placebo 1
Genetic 1
placebo 1
Radiation 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 223
NA 47
Canada 23
Brazil 15
Germany 13
France 12
Israel 10
Japan 9
Netherlands 7
Norway 6
Spain 6
Korea, Republic of 4
Singapore 4
Sweden 4
Taiwan 4
United Kingdom 4
China 3
Italy 3
China|Korea, Republic of|Taiwan 2
Denmark 2
Egypt 2
Malaysia 2
Switzerland 2
United States|Canada 2
United States|Puerto Rico 2
Australia|Belgium|Denmark|Finland|Germany|Netherlands|Spain|United Kingdom 1
Australia|Mexico|United Kingdom 1
Austria|Belgium|Finland|France|Germany|Italy|Netherlands|Portugal|Spain|Sweden|Switzerland|United Kingdom 1
Belgium|France|Ireland|Italy|Mexico|Norway|Spain|Turkey|United Kingdom 1
Belgium|Germany|Hungary|Italy|Netherlands|Poland|Romania|Spain|Sweden|United Kingdom 1
Belgium|Netherlands 1
China|Korea, Republic of|Mexico 1
France|Germany|Netherlands|Norway|Portugal|Spain|Switzerland 1
Greece 1
Iceland 1
India 1
Iran, Islamic Republic of 1
Japan|Korea, Republic of|Taiwan 1
Pakistan 1
Poland 1
Russian Federation 1
Saudi Arabia 1
South Africa 1
Spain|Austria|Belgium|France|Germany|Ireland|Italy|Netherlands|Poland|Romania|Sweden|Ukraine|United Kingdom 1
Switzerland|Sweden|Belgium|Denmark|Finland|France|Germany|Netherlands|Norway|Spain|United Kingdom 1
Turkey 1
United States|Australia|Belgium|Canada|France|Germany|Israel|Italy|Netherlands|Norway|Puerto Rico|South Africa|Sweden|United Kingdom 1
United States|Australia|Netherlands 1
United States|Austria|Belgium|Germany|Netherlands|Portugal|Spain|Sweden|United Kingdom 1
United States|Austria|Canada|France|Germany|Ireland|Italy|Poland|Romania|Spain|Sweden|Ukraine|United Kingdom 1
United States|Belgium|Canada|France|Germany|Italy|Netherlands|Spain|Sweden|United Kingdom 1
United States|Belgium|Canada|Germany|Hungary|Italy|Poland|Spain|Sweden|United Kingdom 1
United States|Belgium|Colombia|Denmark|Germany|Norway|Singapore|South Africa|Sweden 1
United States|Belgium|Colombia|Denmark|Germany|Sweden 1
United States|Canada|Germany|Hungary|Sweden 1
United States|Canada|Puerto Rico 1
United States|China 1
United States|Israel 1

Sites per Study

Site_count Study_Count
1 283
2 27
3 10
4 5
5 13
6 6
7 5
8 7
9 3
11 4
12 7
13 2
14 1
15 2
16 4
17 1
18 1
19 2
20 4
21 6
22 1
23 2
24 3
27 3
29 3
30 1
31 2
35 4
36 2
38 2
41 1
42 1
43 1
45 3
46 1
48 3
50 1
54 1
55 1
56 1
57 1
59 1
60 1
62 1
64 1
65 1
66 1
68 1
73 1
79 1
81 1
89 1
95 1
100 1

Phase

Phase Study_Count
N/A 132
Phase 3 107
Phase 4 96
Phase 2 66
Phase 1 15
Phase 1/Phase 2 12
Phase 2/Phase 3 12
Early Phase 1 4

Number of Arms

Number_of_Arms Count_of_Studies
1 82
2 194
3 74
4 25
5 3
6 2
12 1
NA 63

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 6.00 12.00000 14.0 8.00000 2.000 24.0000 14.0000 3.0000
1st Qu. 19.50 39.75000 18.0 23.50000 49.000 43.5000 106.5000 41.0000
Median 24.50 68.00000 30.0 36.00000 86.000 149.5000 223.0000 99.0000
Mean 33.75 96.41667 35.0 39.33333 124.303 162.0833 277.1471 168.5789
3rd Qu. 38.75 119.25000 41.5 43.00000 148.750 255.0000 328.5000 189.0000
Max. 80.00 504.00000 105.0 89.00000 740.000 340.0000 2017.0000 1344.0000

Trial Group Type

group_type Group_Count
Experimental 431
Active Comparator 175
Placebo Comparator 163
NA 63
No Intervention 32
Other 18
Sham Comparator 12

Intervention Model

intervention_model Study_Count
Parallel Assignment 252
Single Group Assignment 109
Crossover Assignment 71
Factorial Assignment 7
NA 3
Sequential Assignment 2

Primary Purpose

primary_purpose Study_Count
Treatment 387
Basic Science 18
Other 10
Health Services Research 9
Prevention 7
Diagnostic 5
NA 5
Supportive Care 3

Observational Studies

Studies by Country

Country Study_Count
United States 30
Taiwan 9
NA 6
France 5
Israel 4
Canada 2
Italy 2
Korea, Republic of 2
Austria 1
Brazil 1
Denmark 1
Germany 1
Germany|Hungary|Italy|United Kingdom 1
Hong Kong 1
Netherlands 1
Spain 1
United Kingdom 1

Sites per Study

Site_count Study_Count
1 59
2 6
4 1
9 1
10 2

Enrollment Metrics

Measure Observational
Min 10.0000
1st Qu 60.0000
Median 120.0000
Mean 854.8551
3rd Qu 440.0000
Max 17418.0000

Observation Model

observational_model Study_Count
Cohort 23
Case-Only 11
Case Control 11
NA 11
Case-Control 6
Other 2
Case-Crossover 1
Case Control, Natural History 1
Defined Population 1
Ecologic or Community 1
Family-Based 1

Time Perspective

time_perspective Study_Count
Prospective 24
Cross-Sectional 23
NA 15
Other 3
Retrospective 2
Cross-Sectional, Prospective 1
Longitudinal, Prospective 1

Registries

Studies by Country

Country Study_Count
Norway 1
Sweden 1
United States|Australia 1

Sites per Study

Site_count Study_Count
1 2
2 1

Enrollment Metrics

Measure Registries
Min 200
1st Qu 1100
Median 2000
Mean 7400
3rd Qu 11000
Max 20000

Registry Model

observational_model Study_Count
Case-Only 2
Cohort 1

Time Perspective

time_perspective Study_Count
Prospective 3

Follow-up

target_duration Study_Count
12 Months 2
100 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT02402166 Safety, Tolerability, Pharmacokinetic, and Efficacy Study of SPD489 in Preschool Children With Attention-deficit/Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT02402166 Completed Shire 2016-06-30
NCT04085172 A Study to Assess the Safety and Efficacy of Guanfacine Hydrochloride Prolonged Release (SPD503) in Children and Adolescents Aged 6 to 17 Years With Attentiondeficit/Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT04085172 Recruiting Shire 2024-04-29
NCT03368690 Therapeutic Effects of Pine Bark Extracts in Attention Deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT03368690 Completed Taipei Medical University 2019-06-21
NCT04416360 Autism Spectrum Disorder or Attention Deficit Hyperactivity Disorder in Covid-19 Outbreak https://ClinicalTrials.gov/show/NCT04416360 Recruiting University Hospital, Toulouse 2020-07-31
NCT03363568 Neuroplasticity Technology for Attention-deficit/Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT03363568 Completed Boston Children’s Hospital 2014-03-03
NCT03337646 Evaluation of the Effect and Safety of Lisdexamfetamine in Children Aged 6-12 With ADHD and Autism https://ClinicalTrials.gov/show/NCT03337646 Recruiting JPM van Stralen Medicine Professional 2020-10-31
NCT03337425 Psychoeducational Groups for Adults With ADHD https://ClinicalTrials.gov/show/NCT03337425 Recruiting Norwegian University of Science and Technology 2019-06-15
NCT03327402 Safety, Tolerability and Pharmacokinetics of SHP465 in Children Aged 4 to 5 Years With Attention-Deficit/Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT03327402 Completed Shire 2018-10-05
NCT03326427 Group Dialectical Behavior Therapy as add-on Treatment for Adults With Attention Deficit/Hyperactive Disorder https://ClinicalTrials.gov/show/NCT03326427 Completed Hospital de Clinicas de Porto Alegre 2018-11-24
NCT03325881 Efficacy and Safety of SHP465 at 6.25 mg in the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-12 Years https://ClinicalTrials.gov/show/NCT03325881 Completed Shire 2018-06-07
NCT03324581 The Safety and Efficacy of OPC-64005 in the Treatment of Adult Attention-deficit/Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT03324581 Completed Otsuka Pharmaceutical Development & Commercialization, Inc. 2018-10-31
NCT03289793 NEUROFEEDBACK on Event-Related Potential (ERP) https://ClinicalTrials.gov/show/NCT03289793 Completed Hospices Civils de Lyon 2019-09-09
NCT03265119 PART A: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and With mGluR Mutations https://ClinicalTrials.gov/show/NCT03265119 Completed Aevi Genomic Medicine, LLC, a Cerecor company 2018-09-24
NCT03260205 Safety and Efficacy Study in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT03260205 Completed Shire 2018-10-23
NCT03250013 Long-term Effects of Medication for ADHD https://ClinicalTrials.gov/show/NCT03250013 Recruiting Göteborg University 2021-09-30
NCT03220308 Mindfulness Training for Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and Mindful Parenting https://ClinicalTrials.gov/show/NCT03220308 Completed Karakter Kinder- en Jeugdpsychiatrie 2018-07-26
NCT03203928 Effectiveness of a Tailored Occupational Therapy Intervention for Women With ADHD https://ClinicalTrials.gov/show/NCT03203928 Completed Columbia University 2018-01-10
NCT03153488 Attention Deficit Hyperactivity Disorder (ADHD) Prediction of Treatment Response https://ClinicalTrials.gov/show/NCT03153488 Recruiting Massachusetts General Hospital 2020-07-01
NCT03136263 Oxytocin and Cognitive Control in Adult ADHD https://ClinicalTrials.gov/show/NCT03136263 Recruiting Massachusetts General Hospital 2020-09-30
NCT03115671 Efficacy Study of Vayarin in Children With Autism and Comorbid Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT03115671 Completed Institute of Mental Health, Singapore 2018-12-31
NCT03006367 Pharmacokinetic and Tolerability Study of NFC-1 in Subjects Aged 6-17 Years With ADHD https://ClinicalTrials.gov/show/NCT03006367 Completed Aevi Genomic Medicine, LLC, a Cerecor company 2017-02-26
NCT02959528 The Effects of Working Memory Training in Children With Attention-Deficit/Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT02959528 Completed Chang Gung Memorial Hospital 2016-11-25
NCT03231800 A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years Old With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting. https://ClinicalTrials.gov/show/NCT03231800 Completed Sunovion 2019-03-15
NCT02951754 Methylphenidate in Adults With Attention Deficit/Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT02951754 Recruiting Hospital de Clinicas de Porto Alegre 2032-12-31
NCT02937142 Cognitive Behavior Group Therapy in Adolescents With Attention Deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT02937142 Active, not recruiting St. Olavs Hospital 2020-01-31
NCT02911194 a2 Milk for Autism and Attention-deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT02911194 Completed Northumbria University 2018-09-30
NCT02908802 Probiotic Supplement as Treatment for Students With ADHD https://ClinicalTrials.gov/show/NCT02908802 Active, not recruiting Tel Hai College 2019-09-30
NCT02889354 Group-based Cognitive-behavioral Therapy for Adults With Attention-deficit/Hyperactivity Disorder Inattentive-type https://ClinicalTrials.gov/show/NCT02889354 Completed Karolinska Institutet 2017-06-30
NCT02874690 Stimulant Autism Test https://ClinicalTrials.gov/show/NCT02874690 Active, not recruiting Children’s Hospital Medical Center, Cincinnati 2018-10-31
NCT02829970 Helping College Students With ADHD Lead Healthier Lifestyles https://ClinicalTrials.gov/show/NCT02829970 Completed University of Maryland, College Park 2019-09-30
NCT02828644 Software Treatment for Actively Reducing Severity of ADHD - Follow Up https://ClinicalTrials.gov/show/NCT02828644 Completed Akili Interactive Labs, Inc. 2017-12-31
NCT02816151 Children Toxine Botulinum Detrusor Injection in Neurogenic Vesical Hyperactivity Syndrom: Non Inferiority Multicenter Controlled Therapeutic Study Between Two Reported Weight’s Doses https://ClinicalTrials.gov/show/NCT02816151 Completed CHU de Reims 2016-05-31
NCT02808104 Mazindol Controlled Release in Adults With Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT02808104 Completed NLS-1 Pharma Inc. 2017-03-28
NCT02807870 Early Interventions in Children With Attention Deficit/Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT02807870 Enrolling by invitation University of Sao Paulo 2019-12-31
NCT02803229 Treatment of Cannabis Use Disorder Among Adults With Comorbid Attention-Deficit/Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT02803229 Completed New York State Psychiatric Institute 2020-06-30
NCT02795637 Study of the What the Body Does to the Drug in Subjects With Mild, Moderate, and Severe Liver Dysfunction https://ClinicalTrials.gov/show/NCT02795637 Completed Sunovion 2016-11-30
NCT02788851 The Effectiveness of Aerobic Exercise in the Treatment of Adults With Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT02788851 Active, not recruiting McGill University Health Centre/Research Institute of the McGill University Health Centre 2018-12-31
NCT02737033 Effects of 800mg of Rhodiola Rosea in Attention in Adults With Attention-Deficit/Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT02737033 Recruiting Hospital de Clinicas de Porto Alegre 2021-03-31
NCT02737020 Rhodiola Rosea in Adults With Attention Deficit/Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT02737020 Recruiting Hospital de Clinicas de Porto Alegre 2021-03-31
NCT02736656 Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 Extended Release (ER) https://ClinicalTrials.gov/show/NCT02736656 Active, not recruiting Supernus Pharmaceuticals, Inc. 2021-06-30
NCT02734693 A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting. https://ClinicalTrials.gov/show/NCT02734693 Completed Sunovion 2017-02-28
NCT02732496 Computerized Working Memory Training in Children With ADHD and Comorbid Tourette Syndrome https://ClinicalTrials.gov/show/NCT02732496 Completed Massachusetts General Hospital 2017-11-03
NCT02728011 Pilot Trial Comparing Computerised Cognitive Exercises to Tetris in Adolescents With ADHD https://ClinicalTrials.gov/show/NCT02728011 Completed Region Syddanmark 2010-12-31
NCT02716324 Communication to Improve Shared Decision-Making in ADHD https://ClinicalTrials.gov/show/NCT02716324 Completed Children’s Hospital of Philadelphia 2018-05-09
NCT02699086 A Study of PDC-1421 Treatment in Adult Patients With Attention-Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT02699086 Recruiting BioLite, Inc. 2020-05-31
NCT02688959 Motor Attention Training for Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT02688959 Recruiting University of Wisconsin, Madison 2021-06-30
NCT02681575 Meta-cognitive Functional Intervention for Adults With ADHD: A Pilot Efficacy Study https://ClinicalTrials.gov/show/NCT02681575 Completed Hadassah Medical Organization 2017-07-31
NCT02675400 Treatments for Fathers With ADHD and Their At-Risk Children (Fathers Too) https://ClinicalTrials.gov/show/NCT02675400 Completed Seattle Children’s Hospital 2018-08-31
NCT02674633 Software Treatment for Actively Reducing Severity of ADHD https://ClinicalTrials.gov/show/NCT02674633 Completed Akili Interactive Labs, Inc. 2017-07-31
NCT02655276 Sublingual Glycine vs. Placebo on Attentional Difficulties and Hyperactivity in Prepuberal Children https://ClinicalTrials.gov/show/NCT02655276 Completed University Hospital Freiburg 2016-05-31
NCT02642666 The Effects of Yoga on Attention, Impulsivity and Hyperactivity in Pre-school Age Children https://ClinicalTrials.gov/show/NCT02642666 Completed University of California, Davis 2016-03-31
NCT02635035 Shire SCT: Lisdexamfetamine Treatment for ADHD and SCT https://ClinicalTrials.gov/show/NCT02635035 Completed NYU Langone Health 2019-01-09
NCT02604407 Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT02604407 Completed Shire 2016-03-31
NCT02588365 Brain Training in Children With/At-risk for Attention-Deficit/Hyperactivity Disorder and Executive Function Impairment https://ClinicalTrials.gov/show/NCT02588365 Completed Stanford University 2018-12-31
NCT02578030 Pharmacokinetic Study in Children and Adolescents Aged 6 to 17 Years Who Have Been Diagnosed With ADHD https://ClinicalTrials.gov/show/NCT02578030 Completed Shire 2015-11-10
NCT02566824 Cognitive Behavioral Therapy for Adolescents With Attention-Deficit / Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT02566824 Recruiting McGill University Health Centre/Research Institute of the McGill University Health Centre 2020-08-31
NCT02560454 Cognitive Training in Children With Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT02560454 Completed Assistance Publique - Hôpitaux de Paris 2018-09-30
NCT02558790 L-Threonic Acid Magnesium Salt (L-TAMS) in ADHD https://ClinicalTrials.gov/show/NCT02558790 Completed Massachusetts General Hospital 2017-10-31
NCT02547428 Safety and Efficacy Study of Centanafadine Sustained-Release (CTN SR) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT02547428 Completed Otsuka Pharmaceutical Development & Commercialization, Inc. 2016-05-31
NCT02536105 PK/PD Pediatric ADHD Classroom Study https://ClinicalTrials.gov/show/NCT02536105 Completed Massachusetts General Hospital 2018-07-31
NCT02520388 A Pivotal Efficacy Trial to Evaluate HLD200 in Children With ADHD in a Naturalistic Setting https://ClinicalTrials.gov/show/NCT02520388 Completed Ironshore Pharmaceuticals and Development, Inc 2016-04-30
NCT02489279 Training Attentional Awareness and Control in ADHD https://ClinicalTrials.gov/show/NCT02489279 Completed Think Now Incorporated 2016-12-31
NCT02466425 Safety and Efficacy Study of SHP465 in Children and Adolescents Aged 6-17 Years With Attention-Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT02466425 Completed Shire 2016-02-16
NCT02466386 Safety and Tolerability Study of SPD489 in Preschool Children Aged 4-5 Years, Diagnosed With Attention-deficit/Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT02466386 Completed Shire 2019-12-30
NCT02457819 Dasotraline Pediatric Extension Study https://ClinicalTrials.gov/show/NCT02457819 Completed Sunovion 2017-02-02
NCT02428088 Dasotraline Pediatric ADHD Study https://ClinicalTrials.gov/show/NCT02428088 Completed Sunovion 2016-07-31
NCT02358941 Neurofeedback and Computerized Cognitive Training in Different Settings for Children and Adolescents With ADHD https://ClinicalTrials.gov/show/NCT02358941 Completed University of Zurich 2017-03-31
NCT02333149 Melatonin in Youth: N-of-1 Trials in a Stimulant-treated Attention Deficit Hyperactivity Disorder (ADHD) Population https://ClinicalTrials.gov/show/NCT02333149 Active, not recruiting University of Alberta 2022-12-31
NCT02327013 Investigating the Effect of Vortioxetine in Adult ADHD Patients https://ClinicalTrials.gov/show/NCT02327013 Completed H. Lundbeck A/S 2016-09-30
NCT02305134 Tipepidine in Children With Attention Deficit/Hyperactivity Disorder (AD/HD): a Double-blind, Placebo-controlled Trial https://ClinicalTrials.gov/show/NCT02305134 Completed Chiba University 2019-03-31
NCT02286817 Phase I Single Dose, Open-Label Pharmacokinetic Study and Single-Blind, Placebo-Controlled Dose Escalation Study of NFC-1 in Adolescents With Attention-Deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT02286817 Completed Aevi Genomic Medicine, LLC, a Cerecor company 2015-05-31
NCT02286349 Non Invasive Brain Stimulation Effects on Attentional Performance in ADHD Adults https://ClinicalTrials.gov/show/NCT02286349 Completed Universidade Federal de Pernambuco 2015-08-31
NCT02276209 Dasotraline Adult ADHD Study https://ClinicalTrials.gov/show/NCT02276209 Completed Sunovion 2016-09-30
NCT02257216 Vayarin® Medical Food Study for Adults With Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT02257216 Completed Enzymotec 2017-05-31
NCT02255513 A Trial Evaluating the Efficacy and Safety of HLD200 in Children With ADHD https://ClinicalTrials.gov/show/NCT02255513 Completed Ironshore Pharmaceuticals and Development, Inc 2014-10-31
NCT02253745 Safety, Tolerability, PK & Efficacy of V81444 in Volunteers With Attention Deficit/ Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT02253745 Completed Vernalis (R&D) Ltd 2014-03-31
NCT02251743 Double-Blind 2-Site Randomized Clinical Trial of Neurofeedback for ADHD https://ClinicalTrials.gov/show/NCT02251743 Active, not recruiting Ohio State University 2019-04-30
NCT02248948 Superiority of Omega-3 Versus Placebo on the Improvement of ADHD in Children https://ClinicalTrials.gov/show/NCT02248948 Completed Laboratorios Ordesa 2016-07-31
NCT02217371 Role of Circadian and Homeostatic Systems in the Regulation of Wakefulness in Adult Patients With Attention Deficit Disorder With or Without Hyperactivity https://ClinicalTrials.gov/show/NCT02217371 Completed University Hospital, Bordeaux 2017-05-31
NCT02204410 Omega-3 Supplementation to ADHD Medication in Children https://ClinicalTrials.gov/show/NCT02204410 Completed Massachusetts General Hospital 2016-05-31
NCT02195167 Dasotraline SEP360-105 Pediatric PK/PD Study https://ClinicalTrials.gov/show/NCT02195167 Completed Sunovion 2015-03-31
NCT02172183 CBT Group for Adolescents With ADHD: a Randomized Controlled Trial https://ClinicalTrials.gov/show/NCT02172183 Completed Hospital Universitari Vall d’Hebron Research Institute 2014-03-31
NCT02167048 Low-dose vs. Normal-dose Psychostimulants on Executive Functions in Individuals With ADHD https://ClinicalTrials.gov/show/NCT02167048 Recruiting University of British Columbia 2019-12-31
NCT02160262 Open-label Safety Study in Adults With ADHD https://ClinicalTrials.gov/show/NCT02160262 Completed Sunovion 2016-05-31
NCT02151396 Effect of Working Memory Training on ADHD Brain Function https://ClinicalTrials.gov/show/NCT02151396 Completed Hartford Hospital 2013-02-28
NCT02142140 Follow up Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT02142140 Active, not recruiting McGill University Health Centre/Research Institute of the McGill University Health Centre 2019-02-28
NCT02114632 Supplementation of Polyunsaturated Fatty Acids in Children With Attention Deficit/Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT02114632 Completed Medical University of Warsaw 2012-05-31
NCT02105142 Comparative Effectiveness of Primary Care-based Interventions for Pediatric ADHD https://ClinicalTrials.gov/show/NCT02105142 Completed Indiana University 2015-09-30
NCT02096952 Methylphenidate ER Liquid Formulation in Adults With ASD and ADHD https://ClinicalTrials.gov/show/NCT02096952 Completed Massachusetts General Hospital 2018-01-31
NCT02086864 A Placebo Controlled Study of Homeopathic Treatment of Children and Youth With ADHD https://ClinicalTrials.gov/show/NCT02086864 Active, not recruiting University of Toronto 2020-06-30
NCT02083783 TRI102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT02083783 Completed Tris Pharma, Inc. 2014-10-31
NCT02059642 A 6 Week Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD ( Attention Deficit/Hyperactivity ) https://ClinicalTrials.gov/show/NCT02059642 Completed Alcobra Ltd. 2014-09-30
NCT01275378 Comparative Effectiveness Research for Two Medical Home Models for Attention Deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT01275378 Completed Boston Medical Center 2014-06-30
NCT01270555 Efficacy Of Bupropion For Attention Deficit Hyperactivity Disorder (ADHD) In Adults https://ClinicalTrials.gov/show/NCT01270555 Completed Massachusetts General Hospital 2001-07-31
NCT01269463 Time Course of Response to Methylphenidate HCl ER Capsules in Children 6 to 12 Years With ADHD in Classroom Setting https://ClinicalTrials.gov/show/NCT01269463 Completed Rhodes Pharmaceuticals, L.P. 2011-06-30
NCT01986062 Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting https://ClinicalTrials.gov/show/NCT01986062 Completed Arbor Pharmaceuticals, Inc. 2014-05-31
NCT01985581 Efficacy of GXR as Adjunctive Therapy With Psycho-stimulant on Executive Function in Children With ADHD https://ClinicalTrials.gov/show/NCT01985581 Completed JPM van Stralen Medicine Professional 2015-03-31
NCT01982422 Developmental Origins of Attention Deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT01982422 Completed Oregon Health and Science University 2014-05-31
NCT01968512 Neurobiological Aspects of the Attention Deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT01968512 Completed Federal University of Bahia 2014-04-30
NCT01967485 Text Messaging Adherence to Stimulant Medication https://ClinicalTrials.gov/show/NCT01967485 Completed Massachusetts General Hospital 2016-08-31
NCT01943539 Cognitive ADHD Videogame Exploratory Study https://ClinicalTrials.gov/show/NCT01943539 Completed Akili Interactive Labs, Inc. 2015-05-31
NCT01940978 A Study of Combination Therapy in Children With ADHD https://ClinicalTrials.gov/show/NCT01940978 Completed Sears, Douglas, M.D. 2015-03-31
NCT01912352 Gene-environment Interactions and Brain Functional Connectivity in Attention Deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT01912352 Completed Seoul National University 2013-04-30
NCT01907360 Phase I/II Single Center, Open-Label Study Examining Image Result for Pharmacokinetics of 2 Modified-Release Formulations of MPH in Adolescent/Pediatric With ADHD https://ClinicalTrials.gov/show/NCT01907360 Completed Ironshore Pharmaceuticals and Development, Inc 2013-10-31
NCT01886469 A Phase II, Adaptive Trial Design Examining the Pharmacokinetic and Pharmacodynamic Effects of Modified Release Amphetamine (HLD100, Formulations B, C and E)) in Adolescents and Children With Attention-Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT01886469 Completed Ironshore Pharmaceuticals and Development, Inc 2013-09-30
NCT01876524 tRNS in Anterior Cingulate Cortex Reduces Craving Over Dual Pathology Patients https://ClinicalTrials.gov/show/NCT01876524 Completed Spanish Foundation for Neurometrics Development 2014-08-31
NCT01873729 An Open-Label Study of Naltrexone in Adults With Attention Deficit Hyperactivity Disorder. https://ClinicalTrials.gov/show/NCT01873729 Completed Massachusetts General Hospital 2016-06-30
NCT01855984 Tocotrienols for School-going Children With ADHD https://ClinicalTrials.gov/show/NCT01855984 Completed RCSI & UCD Malaysia Campus 2013-06-30
NCT01853280 L-methylfolate Supplementation to OROS-Methylphenidate Pharmacotherapy in ADHD Adults https://ClinicalTrials.gov/show/NCT01853280 Completed Massachusetts General Hospital 2017-02-28
NCT01835548 NT0102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT01835548 Completed Neos Therapeutics, Inc 2014-07-31
NCT01835093 An Open Study of Tipepidine Hibenzate in Patients With Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT01835093 Completed Chiba University 2013-12-31
NCT01831622 Influence of Stimulant Medication on Brain Processes for Decision Making in Attention Deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT01831622 Completed University of Oslo 2015-06-30
NCT01807299 The Effect of Physical Training and the Omega 3 Consumption on Attention Deficit Hyperactivity Disorder in Children https://ClinicalTrials.gov/show/NCT01807299 Completed Federal University of São Paulo 2013-03-31
NCT01796262 The Effects of DHA on Attention Deficit and Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT01796262 Completed IRCCS Eugenio Medea 2015-02-28
NCT01738334 Effects Of The Mindfulness Meditation Practices On Cognition https://ClinicalTrials.gov/show/NCT01738334 Completed Federal University of São Paulo 2012-02-29
NCT01709695 Neurobiological Basis of Response to Guanfacine Extended Release in Children and Adolescents With ADHD https://ClinicalTrials.gov/show/NCT01709695 Completed Icahn School of Medicine at Mount Sinai 2013-12-31
NCT01694667 Omega-3 Fatty Acids for Hyperactivity Treatment in Autism Spectrum Disorder https://ClinicalTrials.gov/show/NCT01694667 Completed Hugo W. Moser Research Institute at Kennedy Krieger, Inc. 2012-12-31
NCT01692782 Adult Attention Deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT01692782 Completed Sunovion 2013-11-30
NCT01686724 Study of the Collaborative Life Skills Program https://ClinicalTrials.gov/show/NCT01686724 Completed University of California, San Francisco 2015-11-30
NCT01678209 Imaging Stimulant and Non Stimulant Treatments for ADHD: A Network Based Approach https://ClinicalTrials.gov/show/NCT01678209 Completed Icahn School of Medicine at Mount Sinai 2018-04-30
NCT01675869 Executive Function/Metacognitive Training for At-Risk Preschoolers https://ClinicalTrials.gov/show/NCT01675869 Completed Children’s Hospital Medical Center, Cincinnati 2015-06-30
NCT01675804 Computer-assisted Cognitive Rehabilitation (CACR), Placebo CACR and Psycho-stimulants in the Treatment of ADHD https://ClinicalTrials.gov/show/NCT01675804 Completed Allameh Tabatabai University 2012-04-30
NCT01660464 Guided Self-Help for Parents of Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT01660464 Completed University of Cologne 2013-11-30
NCT01654250 NWP09 in Children With Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT01654250 Completed Pfizer 2012-10-31
NCT01583829 Study of Computer Attention Training Programs in Schools for Children With Attention Deficit/Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT01583829 Completed Tufts Medical Center 2012-12-31
NCT01557595 Blue Wavelength Light-blocking Glasses in ADHD-Insomnia https://ClinicalTrials.gov/show/NCT01557595 Completed University of Alabama at Birmingham 2012-06-30
NCT01554462 The Effects of EPA/DHA Supplementation on Cognitive Control in Children With ADHD https://ClinicalTrials.gov/show/NCT01554462 Completed Unilever R&D 2013-01-31
NCT01554046 The Effect of Methylphenidate Treatment in Familial Attention Deficit/Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT01554046 Recruiting Sheba Medical Center 2022-03-31
NCT01553695 Adults With Attention Deficit Hyperactivity Disorder (ADHD): Validation of a Clinical Interview and Screening Instruments in French https://ClinicalTrials.gov/show/NCT01553695 Completed Centre Hospitalier Universitaire de Nice 2012-03-31
NCT01552915 Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT01552915 Completed Shire 2014-01-31
NCT01552902 Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT01552902 Completed Shire 2014-05-31
NCT01547702 Classroom-based Distance Intervention for Teachers of Children With Attention Deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT01547702 Completed Dalhousie University 2013-05-31
NCT01542528 Integrated Brain, Body and Social Intervention for Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT01542528 Completed Yale University 2016-07-31
NCT01536210 Efficacy and Safety Study of Combination of Ginkgo Extract and Ginseng Extract in Children With ADHD(Attention Deficit Hyperactivity Disorder) https://ClinicalTrials.gov/show/NCT01536210 Completed Yuyu Pharma, Inc. 2012-08-31
NCT01500694 Access to Extended Release Guanfacine HCl for Subjects Who Participated in Studies SPD503-315 or SPD503-316 in Europe https://ClinicalTrials.gov/show/NCT01500694 Completed Shire 2015-09-15
NCT01487967 Preference and Goal Directed Attention Deficit Hyperactivity Disorder Care- Pilot Study https://ClinicalTrials.gov/show/NCT01487967 Completed Children’s Hospital of Philadelphia 2015-06-30
NCT01472991 Safety & Efficacy of TC-5619 in Adults With Inattentive-predominant Attention Deficit/Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT01472991 Completed Targacept Inc. 2012-07-31
NCT01462032 Non-pharmacological Interventions for Preschoolers With Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT01462032 Completed Queens College, The City University of New York 2014-03-31
NCT01458340 A Study of TD-9855 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT01458340 Completed Theravance Biopharma 2013-10-31
NCT01439126 Efficacy & Safety of KAPVAYâ„¢ Extended-Release in Children & Adolescents With Attention Deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT01439126 Completed Concordia Pharmaceuticals Inc., Barbados 2012-10-31
NCT01431235 CBT for Patients With Attention Deficit Hyperactivity Disorder (ADHD) and Substance Use Disorders https://ClinicalTrials.gov/show/NCT01431235 Completed Arkin 2016-12-31
NCT01415440 Imaging the Effects of Stimulant Medication on Emotional Lability in Patients With ADHD https://ClinicalTrials.gov/show/NCT01415440 Completed New York State Psychiatric Institute 2018-06-30
NCT01388530 Trigeminal Nerve Stimulation for Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT01388530 Completed University of California, Los Angeles 2012-12-31
NCT01369459 Medication Integration in Treatment of Comorbid Adolescent Substance Users/Attention Deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT01369459 Completed The National Center on Addiction and Substance Abuse at Columbia University 2014-03-31
NCT01364662 A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT01364662 Completed Supernus Pharmaceuticals, Inc. 2012-10-31
NCT01363544 Train Your Brain and Exercise Your Heart? Advancing the Treatment for Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT01363544 Completed VU University of Amsterdam 2015-01-31
NCT01357993 A Long-Term Study on Safety of JNS001 in Adults With Attention-Deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT01357993 Completed Janssen Pharmaceutical K.K. 2013-03-31
NCT01352468 Development of a Multi-faceted Cognitive Training Program for Children With Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT01352468 Completed Children’s Hospital Medical Center, Cincinnati 2013-12-31
NCT01351246 Guided Self-Help for Parents of Children With Attention-Deficit/Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT01351246 Completed University of Cologne 2014-02-28
NCT01351064 Using Computers to Assist in the Diagnosis and Treatment of Attention-deficit/Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT01351064 Completed Indiana University 2012-07-31
NCT01344044 Brain-Computer Interface (BCI) Based Intervention for Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT01344044 Completed National Healthcare Group, Singapore 2016-05-13
NCT01338818 Open-label Extension Evaluating Methylphenidate Hydrochloride Extended Release in Adults With Attention Deficit/Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT01338818 Completed Novartis 2013-02-28
NCT01329510 Sleep and Nocturnal Melatonin in Adults With Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT01329510 Completed Assaf-Harofeh Medical Center 2006-12-31
NCT01328756 Lisdexamfetamine Dimesylate 2-year Safety Study in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT01328756 Completed Shire 2014-09-30
NCT01323192 An Efficacy and Safety Study for JNS001 in Adults With Attention-Deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT01323192 Completed Janssen Pharmaceutical K.K. 2012-04-30
NCT01322646 A Randomized Trial of Interventions for Teenage Drivers With Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT01322646 Completed State University of New York at Buffalo 2015-06-30
NCT01320098 Parent Training for Attention Deficit Hyperactivity Disorder (ADHD) Preschoolers https://ClinicalTrials.gov/show/NCT01320098 Completed NYU Langone Health 2014-11-30
NCT04408521 Effects of a Novel Neurofeedback Protocol on ADHD Subcomponents https://ClinicalTrials.gov/show/NCT04408521 Enrolling by invitation University Hospital, Geneva 2023-04-30
NCT04378517 Family Strength Oriented Therapeutic Conversation for Parents of Adolescent With ADHD: Pilot Study https://ClinicalTrials.gov/show/NCT04378517 Completed University of Iceland 2019-02-20
NCT04362982 Αn Information System for Symptom Diagnosis and Improvement of Attention Deficit Hyperactivity Disorder (ADHD360) https://ClinicalTrials.gov/show/NCT04362982 Recruiting Aristotle University Of Thessaloniki 2021-04-30
NCT04355065 The Secret Trail of Moon (Serious Videogame) and Chess on ADHD: a Clinal Trial https://ClinicalTrials.gov/show/NCT04355065 Recruiting Puerta de Hierro University Hospital 2020-11-30
NCT04270526 Minimizing Pain During Office Intradetrussor Botox Injection https://ClinicalTrials.gov/show/NCT04270526 Recruiting Boston Urogynecology Associates 2021-01-31
NCT04229251 Online Mindfulness-Based Intervention for ADHD https://ClinicalTrials.gov/show/NCT04229251 Enrolling by invitation Universiti Tunku Abdul Rahman 2020-12-31
NCT04196881 Effect of Attention Deficit Hyperactivity Disorder Knowledge Improvement Program on Male Primary School Teachers https://ClinicalTrials.gov/show/NCT04196881 Active, not recruiting King Khalid University 2020-01-01
NCT04189575 A Text Messaging (SMS) Intervention to Improve Adherence to Stimulant Medication in Adults With ADHD in the Primary Care Setting https://ClinicalTrials.gov/show/NCT04189575 Recruiting Massachusetts General Hospital 2020-06-30
NCT04189562 A Text Messaging (SMS) Intervention to Improve Adherence to Stimulant Medications in Children With ADHD https://ClinicalTrials.gov/show/NCT04189562 Recruiting Massachusetts General Hospital 2021-02-28
NCT04189536 An SMS Intervention to Improve Adherence to Stimulant Medications in Adults With ADHD https://ClinicalTrials.gov/show/NCT04189536 Active, not recruiting Massachusetts General Hospital 2020-09-30
NCT04167995 Assessment of Probiotics Lactobacillus in the Management of Attention Deficit Hyperactive Disorder https://ClinicalTrials.gov/show/NCT04167995 Recruiting Ain Shams University 2019-11-09
NCT04152629 Real World Evidence of the Efficacy and Safety of FOQUEST https://ClinicalTrials.gov/show/NCT04152629 Recruiting Purdue Pharma, Canada 2020-08-31
NCT04143217 Open-label Study to Evaluate Long-Term Safety and Efficacy of SPN-812 in Adults With ADHD https://ClinicalTrials.gov/show/NCT04143217 Recruiting Supernus Pharmaceuticals, Inc. 2021-07-31
NCT04081363 Open-label, Single-dose Trial to Assess the Pharmacokinetics of Centanafadine Extended-release Capsules in Pediatric Subjects With Attention-deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT04081363 Completed Otsuka Pharmaceutical Development & Commercialization, Inc. 2019-12-21
NCT04065906 Near-infrared Spectroscopy Neurofeedback as a Treatment for Children With Attention Deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT04065906 Recruiting Xijing Hospital 2019-12-31
NCT04003740 TDCS for the Treatment of Inattention Symptoms in Adult ADHD Patients https://ClinicalTrials.gov/show/NCT04003740 Recruiting Hospital de Clinicas de Porto Alegre 2021-07-01
NCT03949413 Correlation Between Balance and Attention in Children With Attention Deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT03949413 Completed Delta University for Science and Technology 2018-11-28
NCT03861585 Emotional Information Processing in Attention Deficit Disorder With or Without Hyperactivity https://ClinicalTrials.gov/show/NCT03861585 Completed Fondation Lenval 2020-03-11
NCT03849807 Chiropractic Care on Behavior, Neurological Function and Quality of Life in ADHD Children - A Pilot Study https://ClinicalTrials.gov/show/NCT03849807 Completed Riphah International University 2019-06-01
NCT03844269 Electroencephalogram (EEG) Study of Inattention Following Treatment With AKL-T01 https://ClinicalTrials.gov/show/NCT03844269 Recruiting Akili Interactive Labs, Inc. 2020-01-01
NCT03788902 OT and Social Cognition in Children With ADHD: Impact of MPH https://ClinicalTrials.gov/show/NCT03788902 Completed Shalvata Mental Health Center 2016-12-01
NCT03730194 A SMART Design to Improve Sleep Disturbance in Adolescents With Neurodevelopmental Disorders https://ClinicalTrials.gov/show/NCT03730194 Recruiting University of Nebraska 2022-01-31
NCT03709940 Brain Connectivity in Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT03709940 Completed King’s College London 2015-01-15
NCT03678844 Taekwondo Practice in Adolescents With Attention Deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT03678844 Completed University of Genova 2017-01-01
NCT03663179 Transcranial Magnetic Stimulation for Attention Deficit/Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT03663179 Completed University of Pennsylvania 2019-03-31
NCT03659929 Adult Attention Deficit Hyperactivity Disorder (ADHD) Study With Amphetamine Sulfate https://ClinicalTrials.gov/show/NCT03659929 Completed Arbor Pharmaceuticals, Inc. 2019-04-18
NCT03610464 Pharmacokinetic Study of DYANAVEL XR (Amphetamine) Extended-release Oral Suspension, in Children Aged 4 to 5 Years https://ClinicalTrials.gov/show/NCT03610464 Completed Tris Pharma, Inc. 2018-05-23
NCT03609619 PART B: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and Without mGluR Mutations https://ClinicalTrials.gov/show/NCT03609619 Completed Aevi Genomic Medicine, LLC, a Cerecor company 2018-11-23
NCT03605849 A Trial Evaluating the Long-term Safety and Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT03605849 Active, not recruiting Otsuka Pharmaceutical Development & Commercialization, Inc. 2021-06-30
NCT03605836 A Trial to Evaluate the Efficacy, Safety, and Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-deficit/Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT03605836 Active, not recruiting Otsuka Pharmaceutical Development & Commercialization, Inc. 2020-06-30
NCT03605680 A Trial Evaluating the Efficacy, Safety, & Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-deficit/Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT03605680 Completed Otsuka Pharmaceutical Development & Commercialization, Inc. 2020-04-11
NCT03597503 Treatment of Impulsive Aggression (IA) in Adolescent With ADHD in Conjunction With Standard ADHD Treatment https://ClinicalTrials.gov/show/NCT03597503 Recruiting Supernus Pharmaceuticals, Inc. 2020-07-29
NCT03595826 Co Morbid Attention Deficit and Hyperactivity Disorder(ADHD) and Developmental Co Ordination Disorder (DCD) https://ClinicalTrials.gov/show/NCT03595826 Recruiting University of KwaZulu 2019-05-30
NCT03565250 A Study of Identity Building in Children With ADHD https://ClinicalTrials.gov/show/NCT03565250 Recruiting University Hospital, Caen 2020-08-04
NCT03547843 The Effects of Peer Co-led Educational Group Intervention for Adults With Attention-Deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT03547843 Recruiting Norwegian University of Science and Technology 2021-12-31
NCT03542643 Omega-3 Polyunsaturated Fatty Acids in Youth With ADHD https://ClinicalTrials.gov/show/NCT03542643 Completed China Medical University Hospital 2017-12-11
NCT03533556 Effects of L-theanine and Caffeine on Attention and Attention-related Brain Activity of Children With Attention Deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT03533556 Completed Texas Tech University 2018-08-31
NCT03481959 Effectiveness of Methylphenidate Late Formula to Reduce Cannabis Use in Young Cannabis-Related Patients and Attention Deficit Disorder Hyperactivity https://ClinicalTrials.gov/show/NCT03481959 Recruiting Assistance Publique - Hôpitaux de Paris 2022-05-30
NCT03469180 Comparison of Treadmill and Whole Body Vibration Training in Children With Attention Deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT03469180 Completed Bezmialem Vakif University 2018-06-01
NCT03468465 Peripheral Transcutaneous Neuromodulation of the Post-tibial Nerve for Solifenacin 10 mg. Hyperactive Bladder Syndrome https://ClinicalTrials.gov/show/NCT03468465 Active, not recruiting Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia 2019-03-31
NCT03446885 Efficacy of Lisdexamfetamine Dimesylate for Promoting Occupational Success in Young Adults With ADHD https://ClinicalTrials.gov/show/NCT03446885 Recruiting State University of New York at Buffalo 2018-12-31
NCT03440346 Biomarker Research in ADHD: the Impact of Nutrition https://ClinicalTrials.gov/show/NCT03440346 Completed Wageningen University 2019-06-21
NCT01259492 Efficacy and Safety Study of Methylphenidate Hydrochloride Extended Release in Adults With Childhood-onset Attention Deficit/Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT01259492 Completed Novartis 2012-08-31
NCT01244490 Efficacy and Safety of Extended-release Guanfacine Hydrochloride in Children and Adolescents Aged 6-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT01244490 Completed Shire 2013-05-31
NCT01239030 Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD https://ClinicalTrials.gov/show/NCT01239030 Completed Rhodes Pharmaceuticals, L.P. 2012-02-29
NCT01238822 Response Variability in Children With Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT01238822 Completed Children’s Hospital Medical Center, Cincinnati 2009-06-30
NCT01238575 Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder https://ClinicalTrials.gov/show/NCT01238575 Completed Yale University 2014-03-31
NCT01228604 Cost-Effectiveness Study Of The Treatment Of Attention Deficit/Hyperactivity Disorder In Brazil https://ClinicalTrials.gov/show/NCT01228604 Completed Hospital de Clinicas de Porto Alegre 2013-12-31
NCT01176136 Organizational Skills Interventions for Children With Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT01176136 Completed Children’s Hospital Medical Center, Cincinnati 2012-06-30
NCT01174355 A Study of ND0801 in Attention Deficit/Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT01174355 Completed NeuroDerm Ltd. 2017-06-30
NCT01161719 Effectiveness Study of Videoconferencing on Teaching Parent Training Skills to Parents of Children With Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT01161719 Completed University of California, Davis 2009-06-30
NCT01160874 Sleepiness and Driving Performances in Adults With Attention-Deficit/ Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT01160874 Completed University Hospital, Bordeaux 2013-07-31
NCT01146002 Language-based Learning Skills and Attention Deficit Hyperactivity Disorder (ADHD): Impact of Treatment With Sustained-release Guanfacine https://ClinicalTrials.gov/show/NCT01146002 Completed Neurology Group of Bergen County, P.A. 2013-02-28
NCT01141634 A Pilot Trial of Homeopathic Treatment for Attention Deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT01141634 Completed University of Toronto 2012-12-31
NCT01106430 Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate https://ClinicalTrials.gov/show/NCT01106430 Completed Shire 2012-07-31
NCT01098058 Cognitive-Behavioural Therapy (CBT) for Adult Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT01098058 Completed South London and Maudsley NHS Foundation Trust 2014-09-30
NCT01081145 Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT01081145 Completed Shire 2013-06-30
NCT01081132 Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl https://ClinicalTrials.gov/show/NCT01081132 Completed Shire 2013-05-31
NCT01074294 Study of the Safety and Efficacy of OPC-34712 as a Complementary Therapy in the Treatment of Adult Attention Deficit/Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT01074294 Completed Otsuka Pharmaceutical Development & Commercialization, Inc. 2011-06-30
NCT01070394 Effectiveness and Duration of Effect of Open Treatment in Attention Deficit Hyperactivity Disorder (ADHD) Patients Treated With Lisdexamfetamine Dimesylate(Vyvanse) https://ClinicalTrials.gov/show/NCT01070394 Completed NYU Langone Health 2012-07-31
NCT01069523 Electrophysiological Effects of Guanfacine Extended Release in Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT01069523 Completed The University of Texas Health Science Center at San Antonio 2011-08-31
NCT01065259 Concerta and Strattera on the Executive Function in Attention Deficit Hyperactivity Disorder (ADHD) Children https://ClinicalTrials.gov/show/NCT01065259 Completed Peking University 2010-12-31
NCT01063153 Diagnostic Utility of Attention Deficit Hyperactivity Disorder (ADHD) by Brain Activity Flow Patterns Analysis Using Evoked Response Potentials https://ClinicalTrials.gov/show/NCT01063153 Completed Massachusetts General Hospital 2012-02-29
NCT01060150 An Efficacy Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention-Deficit/Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT01060150 Completed Janssen Korea, Ltd., Korea 2010-04-30
NCT01056016 Disseminating a Model Intervention to Promote Improved Attention-deficit Hyperactivity Disorder (ADHD) Care in the Community https://ClinicalTrials.gov/show/NCT01056016 Completed Children’s Hospital Medical Center, Cincinnati 2010-07-31
NCT01055119 Effect of Long Chain Polyunsaturated Fatty Acids on Behavior and Cognition in Children With Attention Deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT01055119 Completed University of Ulm 2012-09-30
NCT01040702 The Effect of Methylphenidate on Decision-making Ability of Attention Deficit Hyperactivity Disorder (ADHD) Adults https://ClinicalTrials.gov/show/NCT01040702 Completed Shalvata Mental Health Center 2009-08-31
NCT01022229 The Safety and Efficacy of a Compound Natural Health Product in Children With Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT01022229 Completed The Canadian College of Naturopathic Medicine 2015-11-30
NCT01012778 Implementation of Climb Up Program for Children With Attention Deficit Hyperactivity Disorder (ADHD) and Dyslexia in a School in India https://ClinicalTrials.gov/show/NCT01012778 Completed Climb Up Kids 2015-08-31
NCT01012622 An Efficacy and Safety Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT01012622 Completed Janssen Korea, Ltd., Korea 2009-08-31
NCT01010750 Lisdexamfetamine Dimesylate (LDX) Pilot Cognition Study to Evaluate the Utility of a Standardized Battery of Tests in Adults With Attention-Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT01010750 Completed Shire 2010-02-28
NCT00997984 Tolerability and Efficacy of AM and PM Once Daily Dosing With Extended-release Guanfacine Hydrochloride in Children 6-12 With Attention-Deficit/Hyperactivity Disorder (ADHD) (The ADHD Tempo Study) https://ClinicalTrials.gov/show/NCT00997984 Completed Shire 2010-10-31
NCT00995085 Efficacy Study of Metadoxine SR Formulation in Attention Deficit Hyperactivity Disorder (ADHD) Subjects https://ClinicalTrials.gov/show/NCT00995085 Completed Alcobra Ltd. 2010-10-31
NCT00989950 Study of the Effect of Individualizing Daytrana Wear-times on Sleep in Children With ADHD https://ClinicalTrials.gov/show/NCT00989950 Completed Cox Health Systems 2011-02-28
NCT00983814 Study of Droxidopa Treatment in Adults With Attention Deficit Hyperactivity Disorder With Co-administration of Carbidopa https://ClinicalTrials.gov/show/NCT00983814 Completed Chelsea Therapeutics 2011-05-31
NCT00969618 A Long Term Follow-Up Study for Asian Adult Patients With Attention Deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT00969618 Completed Eli Lilly and Company 2012-01-31
NCT00962104 Atomoxetine to Treat Asian Adult Patients With Attention-Deficit/Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT00962104 Completed Eli Lilly and Company 2011-02-28
NCT00956605 A Trial of Computer-based Attention-training Systems in Children With Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00956605 Completed Tufts Medical Center 2007-06-30
NCT00947973 Comparing School Based Interventions for Adolescents With Attention Deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT00947973 Completed Children’s Hospital Medical Center, Cincinnati 2013-12-31
NCT00940693 Pilot Study of Duloxetine in Adult Attention Deficit Hyperactivity Disorder(ADHD) https://ClinicalTrials.gov/show/NCT00940693 Completed Université de Montréal 2010-12-31
NCT00938743 Driving in Adults With Attention-deficit/Hyperactivity Disorder (ADHD) Before and During Treatment With Atomoxetine https://ClinicalTrials.gov/show/NCT00938743 Completed Central Institute of Mental Health, Mannheim 2009-12-31
NCT00937469 Social Skills Training and Standard Treatment Versus Standard Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00937469 Completed Region Zealand 2011-07-31
NCT00937040 Adult Study / OROS Methylphenidate Hydrochloride (HCL) (OROS MPH) in Adults With Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00937040 Completed Ortho-McNeil Janssen Scientific Affairs, LLC 2010-02-28
NCT00936299 Bupropion for ADHD in Adolescents With Substance Use Disorder https://ClinicalTrials.gov/show/NCT00936299 Completed University of Colorado, Denver 2013-05-31
NCT00930449 Effects Of A Computerized Working Memory Training Program On Attention, Working Memory, And Academics, In Adolescents With Severe ADHD/LD https://ClinicalTrials.gov/show/NCT00930449 Completed The Hospital for Sick Children 2011-01-31
NCT00928148 The Safety and Efficacy of SPD465 in Adults With Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00928148 Completed Shire NA
NCT00922636 A Study of Pediatric Patients With Attention Deficit/Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT00922636 Completed Eli Lilly and Company 2010-12-31
NCT00918567 Impact of Strattera and Behavior Therapy on the Home and School Functioning of Children With ADHD https://ClinicalTrials.gov/show/NCT00918567 Completed State University of New York at Buffalo 2008-05-31
NCT00904670 Quillivant Oral Suspension (Quillivant XR) in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00904670 Completed Pfizer 2009-08-31
NCT00895908 Reducing Attention Deficit Hyperactivity Disorder in Kindergarten and Pre-Kindergarten Children https://ClinicalTrials.gov/show/NCT00895908 Completed Penn State University 2012-04-30
NCT00890292 A Study to Evaluate Pharmacokinetics, Safety and Tolerability After a Single Dose Administration of JNJ-31001074 in Pediatric Patients (12-17 Years) With Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00890292 Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 2009-12-31
NCT00890240 A Study to Evaluate Pharmacokinetics, Safety and Tolerability After a Single Dose Administration of of JNJ-31001074 in Children (6-11 Years) With Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00890240 Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 2009-11-30
NCT00889915 Comparing the Effectiveness of New Versus Older Treatments for Attention Deficit Hyperactivity Disorder (The NOTA Study) https://ClinicalTrials.gov/show/NCT00889915 Completed Duke University 2009-12-31
NCT00886483 Pilot Feasibility Study of Neurofeedback for Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00886483 Completed Ohio State University 2010-09-30
NCT00880217 A Study to Evaluate 3 Different Doses of JNJ-31001074 in the Treatment of Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00880217 Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 2010-01-31
NCT00877487 Safety and Efficacy of Vyvanse in Adults With Attention-Deficit/Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT00877487 Completed Shire 2010-09-30
NCT00874536 Omega-3 Supplementation and Attention-deficit-hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00874536 Completed Hadassah Medical Organization 2011-06-30
NCT00867451 Improving Sleep and Daytime Functioning Among Children Diagnosed With Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00867451 Completed Children’s Hospital Medical Center, Cincinnati 2011-06-30
NCT00866996 Community-based Study Comparing Extended-release Methylphenidate and Atomoxetine in Children With Attention-deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT00866996 Completed McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. NA
NCT00863499 International Study to Predict Optimised Treatment in Attention Deficit/Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT00863499 Active, not recruiting BRC Operations Pty. Ltd. 2019-12-31
NCT00857220 Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia https://ClinicalTrials.gov/show/NCT00857220 Completed Sunovion 2011-10-31
NCT00856973 Safety & Efficacy Study of Study Drug (Eszopiclone) in Children and Adolescents With Attention-deficit/Hyperactivity Disorder - Associated Insomnia https://ClinicalTrials.gov/show/NCT00856973 Completed Sunovion 2011-07-31
NCT00856063 Autonomic Correlates of Impulsivity for Preschool Children With Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00856063 Completed University of Arizona 2009-12-31
NCT00844753 Atomoxetine, Placebo and Parent Management Training in Autism https://ClinicalTrials.gov/show/NCT00844753 Completed University of Rochester 2014-04-30
NCT00842127 Genetic Polymorphism and OROS-Methylphenidate Treatment in Attention Deficit Hyperactivity Disorder(ADHD) https://ClinicalTrials.gov/show/NCT00842127 Completed Bundang CHA Hospital 2008-08-31
NCT00834821 Effectiveness of a Behavioral Treatment Program for Attention Deficit Hyperactivity Disorder, Inattentive Type https://ClinicalTrials.gov/show/NCT00834821 Completed University of California, San Francisco 2013-01-03
NCT00830700 Children’s Attention Deficit Disorder With Hyperactivity (ADHD) Telemental Health Treatment Study https://ClinicalTrials.gov/show/NCT00830700 Completed Seattle Children’s Hospital 2013-02-28
NCT00829881 Effects of Using Betahistine to Treat Adults With Attention Deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT00829881 Completed P2D, Inc. 2009-12-31
NCT02783105 Effects of Early Musical Intervention on Prevalence and Severity of Paroxysmal Sympathetic Hyperactivity After Severe Traumatic Brain Injury https://ClinicalTrials.gov/show/NCT02783105 Recruiting University Hospital, Strasbourg, France 2020-06-30
NCT02493777 A Pivotal Efficacy Trial to Evaluate HLD200 in Children With ADHD in a Classroom Setting https://ClinicalTrials.gov/show/NCT02493777 Completed Ironshore Pharmaceuticals and Development, Inc 2016-02-29
NCT00807222 Effect of Vyvanse on Sleep in Children Aged 6-12 Years With Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00807222 Completed Clinical Study Centers, LLC 2008-08-31
NCT01933880 A Long Term Post-Marketing Study on the EffIcacy and Safety of Osmotic Release Oral System (OROS) Methylphenidate on the Cognitive Functions of Attention Deficit Hyperactivity Disorder (ADHD) Participants https://ClinicalTrials.gov/show/NCT01933880 Completed Xian-Janssen Pharmaceutical Ltd. 2010-11-30
NCT01740206 Should Chronic Stimulant Medications be Continued Preoperatively in Patients With Attention Deficit Hyperactivity Disorder(ADHD) https://ClinicalTrials.gov/show/NCT01740206 Completed Nationwide Children’s Hospital 2015-12-31
NCT00802490 Effectiveness of a Electroencephalogram (EEG) Biofeedback for the Treatment of ADHD https://ClinicalTrials.gov/show/NCT00802490 Completed National Healthcare Group, Singapore 2011-12-31
NCT02580890 Role of Transcranial Direct Current Stimulation (tDCS) in Patients With Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT02580890 Completed Hospital de Clinicas de Porto Alegre 2015-10-31
NCT02695355 ERP Based Single-dose Predictions of Stimulants https://ClinicalTrials.gov/show/NCT02695355 Completed Ostfold Hospital Trust 2013-01-31
NCT02259517 An fMRI Study of Stimulant vs. Non-Stimulant Treatment of ADHD https://ClinicalTrials.gov/show/NCT02259517 Recruiting New York State Psychiatric Institute 2020-07-31
NCT02210728 Efficacy of Cognitive Behavioral Therapy in Treatment of Adults With Attention Deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT02210728 Active, not recruiting McGill University Health Centre/Research Institute of the McGill University Health Centre 2018-10-31
NCT01322048 DASH After TBI Study: Decreasing Adrenergic or Sympathetic Hyperactivity After Traumatic Brain Injury https://ClinicalTrials.gov/show/NCT01322048 Completed Vanderbilt University Medical Center 2015-01-31
NCT03942835 Psychometric Validation of the Competitive Attention Test https://ClinicalTrials.gov/show/NCT03942835 Recruiting Hospices Civils de Lyon 2024-01-21
NCT00794040 A Controlled Trial of Serotonin Reuptake Inhibitors Added to Stimulant Medication in Youth With Severe Mood Dysregulation https://ClinicalTrials.gov/show/NCT00794040 Completed National Institutes of Health Clinical Center (CC) 2018-02-01
NCT00783835 Study to Evaluate the Efficacy and Quality of Life of Long-Acting Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00783835 Completed Janssen-Cilag Farmaceutica Ltda. 2008-10-31
NCT00780208 Evaluating the Methylphenidate Patch to Treat Former Stimulant Users With ADHD https://ClinicalTrials.gov/show/NCT00780208 Completed Medical University of South Carolina 2008-10-31
NCT00778310 Neuroimaging of the Effects of Concerta in the Treatment of ADHD https://ClinicalTrials.gov/show/NCT00778310 Completed The University of Texas Health Science Center at San Antonio 2010-12-31
NCT00776009 Efficacy and Safety of Dex-Methylphenidate Extended Release 30 mg Versus 20 mg in Children (6-12 Years) With Attention-Deficit/Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting. https://ClinicalTrials.gov/show/NCT00776009 Completed Novartis 2008-12-31
NCT00773916 The Role of Adverse Environment Factors, Family Functioning and Parental Psychopathology in the Response to Treatment With Methylphenidate in Children and Adolescents With Attention Deficit/Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT00773916 Completed Federal University of Rio Grande do Sul 2008-07-31
NCT00772161 Pharmacokinetics of Two Extended-Release Formulations of Methylphenidate in Children With Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00772161 Completed University Hospital Freiburg 2008-12-31
NCT00760747 Comparison of Slow and Fast Transition From Stimulants to Atomoxetine in Children and Adolescents With Attention Deficit/Hyperactivity Disorder(ADHD) https://ClinicalTrials.gov/show/NCT00760747 Completed Eli Lilly and Company 2010-08-31
NCT00758160 The Impact of Osmotic Release Oral Delivery System Methylphenidate (OROS MPH) Upon Family of Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00758160 Completed Johnson & Johnson Taiwan Ltd 2008-06-30
NCT00757029 Pharmacogenetic Study of Methylphenidate in Attention Deficit/Hyperactivity Disorder(ADHD) https://ClinicalTrials.gov/show/NCT00757029 Completed Hallym University Medical Center 2008-08-31
NCT00754208 Long Acting Stimulant Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Young Children https://ClinicalTrials.gov/show/NCT00754208 Completed University of Nebraska 2010-01-31
NCT00753012 Cardiovascular Study of Lisdexamfetamine in Healthy and Hypertensive Attention Deficit Hyperactivity Disorder Adults https://ClinicalTrials.gov/show/NCT00753012 Completed Massachusetts General Hospital 2011-03-31
NCT00736255 Attention Deficit Hyperactivity Disorder (ADHD) Smoking Cessation Study https://ClinicalTrials.gov/show/NCT00736255 Completed Duke University 2011-07-31
NCT00735371 Efficacy and Safety of Lisdexamfetamine Dimesylate (LDX) in Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00735371 Completed Shire 2009-04-30
NCT00733356 The Effects of Vyvanse(TM) on Brain Hemodynamics and Reading https://ClinicalTrials.gov/show/NCT00733356 Completed University of California, Irvine 2009-09-30
NCT00723190 Open-Label, Chronic Exposure, Safety Study of CLONICEL (Clonidine HCl Sustained Release) in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00723190 Completed Shionogi Inc. 2010-03-31
NCT00716274 Effects of Atomoxetine on Brain Activation During Attention & Reading Tasks in Participants With ADHD & Comorbid Dyslexia https://ClinicalTrials.gov/show/NCT00716274 Completed Eli Lilly and Company 2016-07-31
NCT00714688 A Study to Evaluate Effectiveness and Safety of Prolonged Release OROS Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT00714688 Completed Janssen-Cilag International NV 2009-04-30
NCT00704990 Combination Natural Health Product in Children With Attention Deficit/Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00704990 Completed The Canadian College of Naturopathic Medicine 2009-12-31
NCT00700427 A Long Term Study of a Medication for Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00700427 Completed Eli Lilly and Company 2011-08-31
NCT00686933 Long Term Safety and Tolerability Study of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00686933 Completed AbbVie 2008-10-31
NCT00640419 Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00640419 Completed AbbVie 2008-07-31
NCT00640185 Safety, Tolerability and Efficacy Study of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00640185 Completed AbbVie 2008-08-31
NCT00636818 Atomoxetine Asian Study in Adult Subjects With Attention-Deficit/Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00636818 Completed Eli Lilly and Company 2008-09-30
NCT00632619 Group-Based Behavioral Therapy Combined With Stimulant Medication for Treating Children With Attention Deficit Hyperactivity Disorder and Impaired Mood https://ClinicalTrials.gov/show/NCT00632619 Completed Florida International University 2011-06-30
NCT00626236 Phase 2a Study of Safety and Tolerability of SPN-810 in Children With ADHD and Persistent Serious Conduct Problems https://ClinicalTrials.gov/show/NCT00626236 Completed Supernus Pharmaceuticals, Inc. 2009-09-30
NCT00619840 Placebo-Controlled Multi-Centre Double-Blind Trial for Adults With Extended-Release Methylphenidate for ADHD https://ClinicalTrials.gov/show/NCT00619840 Completed Medice Arzneimittel Pütter GmbH & Co KG 2006-05-31
NCT00610441 Dose Finding Study in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)(174007/P05805/MK-8777-003) https://ClinicalTrials.gov/show/NCT00610441 Completed Merck Sharp & Dohme Corp. 2009-03-02
NCT00586157 Study of Medication Patch to Treat Children Ages 6-12 With ADHD https://ClinicalTrials.gov/show/NCT00586157 Completed Massachusetts General Hospital 2008-12-31
NCT00585910 Study of Atomoxetine and OROS Methylphenidate to Treat Children and Adolescents Ages 6-17 With ADHD https://ClinicalTrials.gov/show/NCT00585910 Completed Massachusetts General Hospital 2007-12-31
NCT00573534 Pilot Study of Vyvanseâ„¢ In ADHD Adolescents at Risk for Substance Abuse https://ClinicalTrials.gov/show/NCT00573534 Completed New York State Psychiatric Institute 2010-01-31
NCT00568685 Atomoxetine to Treat Korean Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00568685 Completed Eli Lilly and Company 2008-11-30
NCT00566449 A Safety and Effectiveness Study of JNJ-31001074 in Adults With Attention-Deficit/Hyperactivity Disorder. https://ClinicalTrials.gov/show/NCT00566449 Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 2008-07-31
NCT00566371 The Effect of a Once Daily Dose of Atomoxetine (ATX) on ADHD-Related Insomnia in Children and Adolescents https://ClinicalTrials.gov/show/NCT00566371 Completed Rhode Island Hospital 2008-12-31
NCT00564954 A Study of Dex-methylphenidate Extended Release in Children (6-12 Years) With Attention-Deficit/Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00564954 Completed Novartis 2007-11-30
NCT00557960 ADDERALL XR (Mixed Salts of a Single-entity Amphetamine) and STRATTERA ( Atomoxetine Hydrochloride) Compared to Placebo on Simulated Driving Safety and Performance and Cognitive Functioning in Adults With ADHD https://ClinicalTrials.gov/show/NCT00557960 Completed Shire NA
NCT00557011 NRP104, Adderall XR or Placebo in Children Aged 6-12 Years With ADHD https://ClinicalTrials.gov/show/NCT00557011 Completed New River Pharmaceuticals NA
NCT00556959 Study Evaluating the Safety and Efficacy of CLONICEL® to Treat Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00556959 Completed Addrenex Pharmaceuticals, Inc. 2008-08-31
NCT00556296 Phase 3 Randomized Double-Blind Placebo-Controlled Study of NRP104 in Children Aged 6-12 With ADHD https://ClinicalTrials.gov/show/NCT00556296 Completed New River Pharmaceuticals NA
NCT00553319 Study of Adderall-XR for the Treatment of Adult Attention Deficit Hyperactivity Disorder and Cocaine Dependence https://ClinicalTrials.gov/show/NCT00553319 Completed New York State Psychiatric Institute 2013-07-31
NCT00546910 Comparison of Atomoxetine Versus Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00546910 Completed Eli Lilly and Company 2009-05-31
NCT00541346 A Pilot Study of Daytrana TM in Children With Autism Co-Morbid for Attention Deficit Hyperactivity Disorder (ADHD) Symptoms https://ClinicalTrials.gov/show/NCT00541346 Completed University of Oklahoma 2009-05-31
NCT00531752 A Study to Evaluate the Efficacy and Safety of Two Doses of PF-03654746 in Adults With Attention Deficit Hyperactivity Disorder (ADHD). https://ClinicalTrials.gov/show/NCT00531752 Completed Pfizer 2008-09-30
NCT00530335 Atomoxetine Phase 2 Study in Japanese Adult Patients With Attention Deficit/Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00530335 Completed Eli Lilly and Company 2008-04-30
NCT00530257 Study of the Effects of Osmotic-Release Oral System (OROS) Methylphenidate (Concerta) on Attention and Memory https://ClinicalTrials.gov/show/NCT00530257 Completed Children’s Hospital of Philadelphia 2008-06-30
NCT00528697 A Safety and Efficacy Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00528697 Completed AbbVie 2008-04-30
NCT00518232 A Study to Determine Effective and Tolerable Titration Scheme for OROS-Methylphenidate in Children With Attention-deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT00518232 Completed Johnson & Johnson Taiwan Ltd 2007-06-30
NCT00517504 Methylphenidate Study in Young Children With Developmental Disorders https://ClinicalTrials.gov/show/NCT00517504 Completed University of Arizona 2008-03-31
NCT00512291 Subcutaneous Olanzapine for Hyperactive or Mixed Delirium https://ClinicalTrials.gov/show/NCT00512291 Completed M.D. Anderson Cancer Center 2007-08-31
NCT00510276 Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) With Atomoxetine in Young Adults and Its Effects on Functional Outcomes https://ClinicalTrials.gov/show/NCT00510276 Completed Eli Lilly and Company 2009-02-28
NCT00506285 Methylphenidate Transdermal System (MTS) in the Treatment of Adult ADHD https://ClinicalTrials.gov/show/NCT00506285 Completed University of Utah 2009-04-30
NCT00486083 Comparison Atomoxetine Hydrochloride and Comparator in Pediatric Outpatients With ADHD https://ClinicalTrials.gov/show/NCT00486083 Completed Eli Lilly and Company NA
NCT00485875 Safety and Efficacy of Switching From a Stimulant Medication to Atomoxetine in Children and Adolescents With ADHD https://ClinicalTrials.gov/show/NCT00485875 Completed Eli Lilly and Company NA
NCT00485797 Effects of Ritalin on Postural Stability of Hyper Active Children https://ClinicalTrials.gov/show/NCT00485797 Completed Soroka University Medical Center 2008-03-31
NCT00485628 Safety Study in Outpatient Japanese Children With ADHD https://ClinicalTrials.gov/show/NCT00485628 Completed Eli Lilly and Company NA
NCT00485550 Comparison of Atomoxetine Plus Either Comparator or Placebo in Children With ADHD Who Haven’t Responded to Stimulant Therapy https://ClinicalTrials.gov/show/NCT00485550 Completed Eli Lilly and Company NA
NCT00485459 Atomoxetine Hydrochloride Versus Placebo in Taiwanese Children and Adolescents With ADHD https://ClinicalTrials.gov/show/NCT00485459 Completed Eli Lilly and Company NA
NCT00483106 Clinical and Pharmacogenetic Study of Attention Deficit With Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00483106 Recruiting McGill University 2023-12-31
NCT00482313 Efficacy and Effectiveness of Methylphenidate in Swedish Male Prison Inmates With Attention-deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00482313 Completed Psychiatry Karolinska 2010-04-30
NCT00475735 A Study to Test the Safety and Efficacy of MK0249 in Patients With ADHD (0249-018)(COMPLETED) https://ClinicalTrials.gov/show/NCT00475735 Completed Merck Sharp & Dohme Corp. 2008-04-30
NCT00471354 A Study for Patients With Attention-Deficit/Hyperactivity Disorder Treated With Atomoxetine https://ClinicalTrials.gov/show/NCT00471354 Completed Eli Lilly and Company 2008-11-30
NCT00467428 Efficacy and Safety of NS2359 in Adults With Attention Deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT00467428 Completed NeuroSearch A/S NA
NCT00466791 Classroom Study to Assess Efficacy and Safety of MTS in Pediatric Patients Aged 6-12 With ADHD https://ClinicalTrials.gov/show/NCT00466791 Completed Noven Therapeutics 2005-05-31
NCT00447278 A Study Comparing the Effect of Atomoxetine Versus Other Standard Care Therapy on the Long Term Functioning in Attention-Deficit/Hyperactivity Disorder (ADHD) Children and Adolescents https://ClinicalTrials.gov/show/NCT00447278 Completed Eli Lilly and Company 2009-03-31
NCT00444574 Safety and Efficacy of MTS Versus Concerta in Pediatric Patients (Aged 6-12 Years) With ADHD https://ClinicalTrials.gov/show/NCT00444574 Completed Noven Therapeutics 2005-06-30
NCT00443391 A Safety and Tolerability Study of ABT-089 in Adults With Attention Deficit-Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00443391 Completed AbbVie 2008-10-31
NCT00434213 Characterization of Dermal Reactions in Pediatric Patients With ADHD Using DAYTRANA https://ClinicalTrials.gov/show/NCT00434213 Completed Noven Therapeutics 2007-08-31
NCT00429273 Single Versus Combination Medication Treatment for Children With Attention Deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT00429273 Completed University of California, Los Angeles 2011-07-31
NCT00429091 A Dose-Ranging Study of the Efficacy of ABT-894 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00429091 Completed Abbott 2007-08-31
NCT00428792 Safety and Efficacy of Methylphenidate in Children With Attention-deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00428792 Completed Novartis 2007-12-31
NCT00419445 Safety and Efficacy of GTS21 in Adults With Attention-deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT00419445 Completed CoMentis 2008-01-31
NCT00418262 Open-Label Study of the Long Term Tolerability and Safety of Atomoxetine in Children With FASD and ADD/ADHD https://ClinicalTrials.gov/show/NCT00418262 Completed University of Oklahoma 2015-04-22
NCT00418184 The Efficacy and Safety of Phosphatidylserine-Omega3 in Children With Attention-Deficit/ Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT00418184 Completed Enzymotec 2008-11-30
NCT00417794 Assess the Effectiveness of Atomoxetine in Children With Fetal Alcohol Syndrome and ADD/ADHD https://ClinicalTrials.gov/show/NCT00417794 Completed University of Oklahoma 2015-04-22
NCT00414921 Preschool Supplement to Clonidine in ADHD (Kiddie-CAT) https://ClinicalTrials.gov/show/NCT00414921 Completed University of Cincinnati NA
NCT00409708 Effects of Methylphenidate on Cellular Abnormalities in Children With Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00409708 Completed Novartis 2008-03-31
NCT00406354 Comparison of Atomoxetine Versus Placebo in Children and Adolescents With ADHD and Comorbid ODD in Germany https://ClinicalTrials.gov/show/NCT00406354 Completed Eli Lilly and Company 2009-01-31
NCT00399763 Atomoxetine for Attention Deficit Hyperactivity Disorder in Adolescents With Substance Use Disorder https://ClinicalTrials.gov/show/NCT00399763 Completed Denver Health and Hospital Authority 2008-02-29
NCT00799487 CONCERTA Lab School Study https://ClinicalTrials.gov/show/NCT00799487 Completed Ortho-McNeil Janssen Scientific Affairs, LLC 2009-06-26
NCT00393042 Sleep and Tolerability Study: Comparing the Effects of Adderall XR and Focalin XR https://ClinicalTrials.gov/show/NCT00393042 Completed Seattle Children’s Hospital 2009-02-28
NCT00391729 A Dose-Ranging, Cross-over Study of the Safety and Efficacy of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00391729 Completed Abbott 2007-06-30
NCT00386581 Efficacy, Tolerability, and Safety of Once-Daily Atomoxetine Hydrochloride Versus Placebo in Russian Children and Adolescents With Attention-Deficit/Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT00386581 Completed Eli Lilly and Company NA
NCT00382616 Supplementation of Phosphatidylserine (PS) and n-3 Long Chain Fatty Acids (EPA, DHA) in Children With ADHD https://ClinicalTrials.gov/show/NCT00382616 Completed Tel-Aviv Sourasky Medical Center NA
NCT00381758 The COMACS Study: A Comparison of Methylphenidates in an Analog Classroom Setting https://ClinicalTrials.gov/show/NCT00381758 Completed UCB Pharma 2002-08-31
NCT00381407 Organizational Skills Training for Children With Attention Deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT00381407 Completed NYU Langone Health 2011-02-28
NCT00380692 Atomoxetine Versus Placebo for Symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children and Adolescents With Autism Spectrum Disorder https://ClinicalTrials.gov/show/NCT00380692 Completed Eli Lilly and Company 2008-05-31
NCT00799409 Lab School Day Study for CONCERTA of Older Children With ADHD https://ClinicalTrials.gov/show/NCT00799409 Completed Ortho-McNeil Janssen Scientific Affairs, LLC 2009-06-30
NCT00356070 Treatment of Prisoners With Attention Deficit Hyperactive Disorder in Trondheim Prison https://ClinicalTrials.gov/show/NCT00356070 Completed Norwegian University of Science and Technology 2006-12-31
NCT00343811 Study to Evaluate the Efficacy of Modafinil Treatment in Patients With Attention Deficit Hyperactivity Disorder (ADHD) Who Are Responders to Modafinil Treatment https://ClinicalTrials.gov/show/NCT00343811 Completed Teva Pharmaceutical Industries NA
NCT00337285 An Open-label Study of NRP104 in Adults With Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00337285 Completed New River Pharmaceuticals 2007-11-30
NCT00334880 Study to Assess the Safety and Efficacy of NRP104 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00334880 Completed New River Pharmaceuticals NA
NCT00326391 A Safety and Effectiveness Study of Methylphenidate HCl Extended-release Tablets in Adults With Attention Deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT00326391 Completed McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. 2006-12-31
NCT00326300 A Long-Term Safety Study to Evaluate Methylphenidate HCL Tablets at Multiple Dose Levels in Adults With Attention Deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT00326300 Completed McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. NA
NCT00323947 Methylphenidate for Treating Attention Deficit Hyperactivity Disorder in Children With Both ADHD and Epilepsy https://ClinicalTrials.gov/show/NCT00323947 Completed Boston Children’s Hospital 2007-11-30
NCT00320528 Efficacy of Atomoxetine on Psychosocial Function of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00320528 Completed Eli Lilly and Company 2008-10-31
NCT00318448 Efficacy, Safety, and Tolerability of Ambien (Zolpidem) in the Treatment of Children Ages 6 to 17 With Attention Deficit Hyperactivity Disorder (ADHD)-Associated Insomnia https://ClinicalTrials.gov/show/NCT00318448 Completed Sanofi 2006-08-31
NCT00316290 Integrated Parent Training for Treating Depression in Mothers of Children With Attention Deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT00316290 Completed University of Maryland, College Park 2010-12-31
NCT00315276 Dose-Finding Study to Evaluate the Efficacy and Safety of Modafinil as Treatment for Adults With ADHD https://ClinicalTrials.gov/show/NCT00315276 Completed Teva Pharmaceutical Industries NA
NCT00307684 Open Label, Multicentre Extension Study of Protocol 42603ATT3002 to Evaluate Safety of Prolonged Release OROS Methlyphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00307684 Completed Janssen-Cilag International NV 2008-07-31
NCT00305370 Aripiprazole Associated With Methylphenidate in Children and Adolescents With Bipolar Disorder and ADHD https://ClinicalTrials.gov/show/NCT00305370 Completed Federal University of Rio Grande do Sul 2008-01-31
NCT00304681 An Effectiveness and Safety Study of CONCERTA* vs. Immediate Release Methylphenidate (IR MPH) in Attention Deficit Hyperactivity Disorder Children https://ClinicalTrials.gov/show/NCT00304681 Completed Janssen-Ortho Inc., Canada NA
NCT00291070 Effects of L-Theanine in Boys With ADHD https://ClinicalTrials.gov/show/NCT00291070 Completed University of British Columbia 2006-07-31
NCT00278473 Psychosocial Treatment for Attention Deficit Hyperactivity Disorder in Adults https://ClinicalTrials.gov/show/NCT00278473 Completed Icahn School of Medicine at Mount Sinai 2008-10-31
NCT00269815 Long-term Safety and Effectiveness of OROS Methylphenidate HCl in Children With Attention Deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT00269815 Completed Alza Corporation, DE, USA NA
NCT00269802 A Multicenter Study Comparing the Efficacy and Safety of OROS Methylphenidate HCl, Ritalin (Methylphenidate HCl) and Placebo in Children With Attention Deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT00269802 Completed Alza Corporation, DE, USA NA
NCT00269789 A Comparative Effectiveness Study Evaluating OROS Methylphenidate HCl, Ritalin (Methylphenidate HCl), and Placebo for the Treatment of Attention Deficit Hyperactivity Disorder in Children https://ClinicalTrials.gov/show/NCT00269789 Completed Alza Corporation, DE, USA NA
NCT00269776 An Effectiveness and Safety Study Evaluating OROS Methylphenidate Hydrochloride (HCl), Ritalin (Methylphenidate HCl) and Placebo in Children With Attention Deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT00269776 Completed Alza Corporation, DE, USA NA
NCT00267605 Strongest Families (Formerly Family Help Program): Pediatric Attention Deficit/Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT00267605 Completed IWK Health Centre 2006-06-30
NCT00257725 Long Duration Stimulant Treatment Study of Preschoolers With ADHD-Feasibility Study https://ClinicalTrials.gov/show/NCT00257725 Completed New York State Psychiatric Institute 2008-03-31
NCT00254462 Atomoxetine for Treating Attention Deficit Hyperactivity Disorder in Young Children https://ClinicalTrials.gov/show/NCT00254462 Completed University of Nebraska 2008-08-31
NCT00249353 An Effectiveness and Safety Study of CONCERTA® (Methylphenidate Hydrochloride) in the Treatment of Adolescents With Attention Deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT00249353 Completed McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. NA
NCT00248092 Study to Evaluate the Likeability, Safety, and Abuse Potential of NRP 104 in Adults With Histories of Stimulant Abuse https://ClinicalTrials.gov/show/NCT00248092 Completed New River Pharmaceuticals NA
NCT00247572 Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse Histories https://ClinicalTrials.gov/show/NCT00247572 Completed New River Pharmaceuticals NA
NCT00246220 A Study of the Effectiveness and Safety of Prolonged-release Methylphenidate Hydrochloride in Adult Patients With Attention Deficit/Hyperactivity Disorder. https://ClinicalTrials.gov/show/NCT00246220 Completed Janssen Pharmaceutica N.V., Belgium NA
NCT00246207 CONCERTA (OROS Methylphenidate Hydrochloride) for the Treatment of Attention Deficit Hyperactivity Disorder in Adults https://ClinicalTrials.gov/show/NCT00246207 Completed Janssen-Ortho Inc., Canada NA
NCT00228046 Medication Strategies for Treating Aggressive Behavior in Youth With Attention Deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT00228046 Completed Stony Brook University 2007-07-31
NCT00221962 Study of Aripiprazole (Abilify) in Children With ADHD (Attention Deficit Hyperactivity Disorder) https://ClinicalTrials.gov/show/NCT00221962 Completed University Hospitals Cleveland Medical Center 2007-04-30
NCT00218543 Atomoxetine for Treating Cocaine Abuse in Adults With Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00218543 Completed New York State Psychiatric Institute 2007-03-31
NCT00218322 Effectiveness of ATMX in Treating Adolescents With ADHD and SUD https://ClinicalTrials.gov/show/NCT00218322 Completed Massachusetts General Hospital 2006-03-31
NCT00216918 Neuropsychological Functioning in Children With Attention-Deficit/Hyperactivity Disorder. https://ClinicalTrials.gov/show/NCT00216918 Completed Eli Lilly and Company NA
NCT00214981 Evaluate the Safety and Efficacy of Modafinil in Children and Adolescents With ADHD https://ClinicalTrials.gov/show/NCT00214981 Completed Teva Pharmaceutical Industries 2006-09-30
NCT00202605 Safety and Efficacy of SPD465 in Adults With ADHD https://ClinicalTrials.gov/show/NCT00202605 Completed Shire NA
NCT00192023 An Italian Study of the Efficacy of Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) and Comorbid Oppositional Defiant Disorder (ODD). https://ClinicalTrials.gov/show/NCT00192023 Completed Eli Lilly and Company 2006-08-31
NCT00191945 Efficacy and Safety of Atomoxetine in Children With Recent Diagnosis of Attention-Deficit/Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00191945 Completed Eli Lilly and Company 2008-02-29
NCT00191906 Comparison of Atomoxetine and Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and/or Reading Disorder (RD) https://ClinicalTrials.gov/show/NCT00191906 Completed Eli Lilly and Company 2007-12-31
NCT00191880 Open-Label Trial of Atomoxetine to Evaluate Academic Outcome in Children Ages 8-11 Years With Attention Deficit/Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT00191880 Completed Eli Lilly and Company NA
NCT00191737 An Open-Label Study of Atomoxetine in Adolescents With Attention-Deficit/Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT00191737 Completed Eli Lilly and Company NA
NCT00191698 Comparison of Atomoxetine and Placebo in Children and Adolescents With ADHD and ODD https://ClinicalTrials.gov/show/NCT00191698 Completed Eli Lilly and Company 2005-06-30
NCT00191659 Study of Broader Efficacy of Atomoxetine in the Treatment of ADHD in Children/Adolescents https://ClinicalTrials.gov/show/NCT00191659 Completed Eli Lilly and Company NA
NCT00191633 Study of Atomoxetine in Children With ADHD to Assess Symptomatic and Functional Outcomes https://ClinicalTrials.gov/show/NCT00191633 Completed Eli Lilly and Company NA
NCT00191542 Atomoxetine vs Placebo in the Treatment of ADHD in Swedish Children and Adolescents https://ClinicalTrials.gov/show/NCT00191542 Completed Eli Lilly and Company NA
NCT00191516 An Open-Label Study of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT00191516 Completed Eli Lilly and Company NA
NCT00191386 Long-Term Study of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder (AD/HD) https://ClinicalTrials.gov/show/NCT00191386 Completed Eli Lilly and Company 2009-08-31
NCT00191295 Atomoxetine Versus Placebo in Children With Attention Deficit/Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00191295 Completed Eli Lilly and Company NA
NCT00191048 Treatment With Atomoxetine Hydrochloride in Children and Adolescents With ADHD https://ClinicalTrials.gov/show/NCT00191048 Completed Eli Lilly and Company NA
NCT00190931 A Functional Outcomes Study With Atomoxetine-Hydrochloride and Placebo in Adults With Attention-Deficit/Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT00190931 Completed Eli Lilly and Company NA
NCT00190775 A Randomized, Double-Blind Comparison of Placebo and Atomoxetine Hydrochloride Given Once a Day in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00190775 Completed Eli Lilly and Company 2009-07-31
NCT00190684 Long-Term, Open Label Atomoxetine Study https://ClinicalTrials.gov/show/NCT00190684 Completed Eli Lilly and Company 2009-10-31
NCT00183391 Stimulant Versus Nonstimulant Medication for Attention Deficit Hyperactivity Disorder in Children https://ClinicalTrials.gov/show/NCT00183391 Completed Icahn School of Medicine at Mount Sinai 2011-06-30
NCT00179894 Improving Attention Deficit Hyperactivity Disorder Treatment Adherence and Outcome in Primary Care Settings https://ClinicalTrials.gov/show/NCT00179894 Completed Ann & Robert H Lurie Children’s Hospital of Chicago 2009-07-31
NCT00178503 Methylphenidate for Attention Deficit Hyperactivity Disorder and Autism in Children https://ClinicalTrials.gov/show/NCT00178503 Completed The University of Texas Health Science Center, Houston 2011-05-31
NCT00174226 Treatment of Adult ADHD With Atomoxetine or Atomoxetine and Buspar https://ClinicalTrials.gov/show/NCT00174226 Completed Pfizer NA
NCT00152035 Safety of SPD465 in Treating Adults With ADHD. https://ClinicalTrials.gov/show/NCT00152035 Completed Shire NA
NCT00152022 Efficacy and Safety of SPD465 in Adults With Moderately Symptomatic ADHD. https://ClinicalTrials.gov/show/NCT00152022 Completed Shire NA
NCT00152009 Safety and Efficacy of SPD503 in Treating Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-17 https://ClinicalTrials.gov/show/NCT00152009 Completed Shire 2006-03-31
NCT00151996 Safety and Tolerability of SPD503 and Psychostimulants in Children and Adolescents Aged 6-17 With Attention-Deficit/Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00151996 Completed Shire 2006-05-31
NCT00151970 Efficacy, Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHD https://ClinicalTrials.gov/show/NCT00151970 Completed Noven Therapeutics 2006-10-31
NCT00151957 Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHD and Previously Participated in MTS Trials https://ClinicalTrials.gov/show/NCT00151957 Completed Noven Therapeutics 2007-06-30
NCT00150618 Safety and Efficacy of SPD503 in Treating ADHD in Children and Adolescents Aged 6-17 https://ClinicalTrials.gov/show/NCT00150618 Completed Shire 2006-05-31
NCT00150592 Safety, Tolerability and Efficacy of SPD503 in Treating ADHD in Children Aged 6-17 https://ClinicalTrials.gov/show/NCT00150592 Completed Shire 2006-04-30
NCT00150579 Efficacy and Safety of SPD465 in Adults With ADHD https://ClinicalTrials.gov/show/NCT00150579 Completed Shire NA
NCT00142961 Atomoxetine for Treating Marijuana-Abusing Adolescents Who Have Attention Deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT00142961 Completed New York State Psychiatric Institute 2007-01-31
NCT00819611 Working Memory Training in Young ADHD Children https://ClinicalTrials.gov/show/NCT00819611 Completed Radboud University 2013-05-31
NCT00118911 Cognitive Behavioral Therapy for Treatment of Adult Attention Deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT00118911 Completed Massachusetts General Hospital 2009-07-31
NCT00116259 Aripiprazole in Children and Adolescents With Bipolar Disorder and Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00116259 Completed Federal University of Rio Grande do Sul 2008-01-31
NCT00819429 Supplements and Social Skills Intervention Study https://ClinicalTrials.gov/show/NCT00819429 Completed National Healthcare Group, Singapore 2014-06-30
NCT00100295 Herbal Treatment for Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00100295 Completed National Center for Complementary and Integrative Health (NCCIH) NA
NCT00071656 Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type I https://ClinicalTrials.gov/show/NCT00071656 Completed University of California, San Francisco NA
NCT00050622 Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00050622 Completed Florida International University 2004-08-31
NCT00050050 Cognitive Behavioral Therapy for Adult Attention Deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT00050050 Completed Massachusetts General Hospital 2003-08-31
NCT00048360 Attention-Deficit Hyperactivity Disorder (ADHD) Study With Adults https://ClinicalTrials.gov/show/NCT00048360 Completed GlaxoSmithKline 2003-06-30
NCT00031395 Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) in Children https://ClinicalTrials.gov/show/NCT00031395 Completed University of Cincinnati NA
NCT00025779 Methylphenidate in Children and Adolescents With Pervasive Developmental Disorders https://ClinicalTrials.gov/show/NCT00025779 Completed National Institute of Mental Health (NIMH) 2003-11-30
NCT00018863 Treatment of Attention Deficit Hyperactivity Disorder in Preschool-Age Children (PATS) https://ClinicalTrials.gov/show/NCT00018863 Active, not recruiting New York State Psychiatric Institute 2006-03-31
NCT00730249 Quality Assurance of Administering Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD) - QUMEA https://ClinicalTrials.gov/show/NCT00730249 Completed Medice Arzneimittel Pütter GmbH & Co KG 2010-01-31
NCT00012584 Treatment of Youth With ADHD and Anxiety https://ClinicalTrials.gov/show/NCT00012584 Completed National Institute of Mental Health (NIMH) 2002-05-31
NCT00000388 Multimodal Treatment Study of Children With Attention Deficit and Hyperactivity Disorder (MTA) https://ClinicalTrials.gov/show/NCT00000388 Completed NYU Langone Health NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03283579 Fatty Acids and Attention Deficit and Hyperactivity Disorder Symptoms https://ClinicalTrials.gov/show/NCT03283579 Completed Barcelona Institute for Global Health 2015-12-31
NCT03233867 A Non-interventional Study to Identify Children and Adolescents With ADHD and With or Without mGLuR Mutations https://ClinicalTrials.gov/show/NCT03233867 Completed Aevi Genomic Medicine, LLC, a Cerecor company 2018-08-03
NCT02942225 The Metabolome Profiling and Pathway Analysis of ADHD https://ClinicalTrials.gov/show/NCT02942225 Recruiting National Taiwan University Hospital 2019-07-31
NCT02918214 Prognostic Assessment of Diastolic and Systolic Left Ventricular Function in Septic Shock https://ClinicalTrials.gov/show/NCT02918214 Completed University Hospital, Limoges 2019-10-31
NCT02811211 A Noninterventional Genotype/Phenotype Study of mGluR Mutations in Children and Adolescents With ADHD https://ClinicalTrials.gov/show/NCT02811211 Completed Aevi Genomic Medicine, LLC, a Cerecor company 2017-01-06
NCT02730572 Concerta (Methylphenidate) -To-Generic Switch Study https://ClinicalTrials.gov/show/NCT02730572 Completed Janssen Research & Development, LLC 2016-10-31
NCT00046059 Genetic Analysis of Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00046059 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001246 Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Volunteers https://ClinicalTrials.gov/show/NCT00001246 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT02430896 Identification of Neuropsychological, Genetic and Neuroimaging Markers and Treatment Response Predictors of ADHD https://ClinicalTrials.gov/show/NCT02430896 Recruiting Asan Medical Center 2020-06-30
NCT02407496 Neurophysiological Attention Test (NAT) for Objective Assessment of Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT02407496 Completed Think Now Incorporated 2015-07-31
NCT02364817 ADHD: Gaps Between Patients With Alcohol-dependence and Impact on Relapse https://ClinicalTrials.gov/show/NCT02364817 Recruiting University Hospital, Lille 2020-02-29
NCT02251080 Attention Deficit/Hyperactivity Disorder Internet Survey Study in a College Student Population https://ClinicalTrials.gov/show/NCT02251080 Completed Wake Forest University Health Sciences 2015-12-31
NCT02232464 Disturbed Structural Connectivity of Frontostriatal and Frontoparietal Networks in Adults With ADHD https://ClinicalTrials.gov/show/NCT02232464 Completed National Taiwan University Hospital 2014-12-31
NCT02226445 Treatment Drop-out and Missed Appointments Among Adults With ADHD https://ClinicalTrials.gov/show/NCT02226445 Completed University of Aarhus 2013-01-31
NCT01310439 Attention-Deficit/Hyperactivity Disorder (ADHD) Brain Activity Changes to Psychostimulants https://ClinicalTrials.gov/show/NCT01310439 Completed Hartford Hospital 2010-06-30
NCT01272726 Influence of Education on Acceptance of Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Among Women https://ClinicalTrials.gov/show/NCT01272726 Completed Avera McKennan Hospital & University Health Center 2010-12-31
NCT04228094 Assesment of TDApp1 an eHelath Tool to Make Therapeutic Recommendations for Patients With ADHD https://ClinicalTrials.gov/show/NCT04228094 Recruiting Universitat de Girona 2020-12-31
NCT01721720 Genetic, Brain Structure, and Environmental Effects on ADHD https://ClinicalTrials.gov/show/NCT01721720 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT01705613 Cost-effectiveness of the Treatment of Attention Deficit/Hyperactivity Disorder With Methylphenidate Immediate-release in Brazil https://ClinicalTrials.gov/show/NCT01705613 Completed Hospital de Clinicas de Porto Alegre 2014-04-30
NCT01677819 Inhibition Control of Children and Adolescents With ADHD https://ClinicalTrials.gov/show/NCT01677819 Completed National Taiwan University Hospital NA
NCT01624649 A Study to Examine the Progression of Attention-Deficit Hyperactivity Disorder (ADHD) Drug Treatment and to Analyze Associated Factors https://ClinicalTrials.gov/show/NCT01624649 Completed Janssen Korea, Ltd., Korea 2014-04-30
NCT01615679 Integrated Diagnosis and Treatment of Adults With Attention-deficit/Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT01615679 Completed Medice Arzneimittel Pütter GmbH & Co KG 2014-03-31
NCT01470261 Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects https://ClinicalTrials.gov/show/NCT01470261 Completed NHS Tayside 2016-01-31
NCT01452061 Evaluating the Validity of a Genetic Risk Assessment Tool in Identifying Autism Spectrum Disorder https://ClinicalTrials.gov/show/NCT01452061 Completed The Cleveland Clinic 2013-12-31
NCT01430767 Measuring Adherence to Medication for Depression and Attention-deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT01430767 Completed Wake Forest University Health Sciences 2014-12-31
NCT01395160 Female Experiences and Brain Activity https://ClinicalTrials.gov/show/NCT01395160 Completed King’s College London 2012-11-30
NCT04412499 Study of the Link Between Psychosocial Treatments and the Need of Pharmacological Treatments in Children With Attention Deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT04412499 Recruiting University Hospital, Montpellier 2020-06-30
NCT04113551 A Study of Label Compliance for Attention Deficit/Hyperactivity Disorder (ADHD) Medications in Japan https://ClinicalTrials.gov/show/NCT04113551 Completed Janssen Research & Development, LLC 2020-01-10
NCT04038073 TLR Polymorphism, ASO and Beta-hemolytic Group A Streptococcus Infections in ADHD: an Observational Study https://ClinicalTrials.gov/show/NCT04038073 Recruiting University of Turin, Italy 2020-06-30
NCT03954769 A Pilot Study of “Stanford Proxy Test for Delirium” (S-PTD) https://ClinicalTrials.gov/show/NCT03954769 Completed Stanford University 2016-01-31
NCT03901859 Metabolic Pathway of Tryptophan and Executive Dysfunction in Children With Attention Deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT03901859 Recruiting National Taiwan University Hospital 2020-03-31
NCT03879343 The Prevalence and Predictors of Gastrointestinal Symptoms in Children With Attention Deficit / Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT03879343 Recruiting Hospital Authority, Hong Kong 2019-07-31
NCT03721588 Clinical and Suicidal Features of Urban, Turkish Middle Age Depressive Patients With Comorbid ADHD https://ClinicalTrials.gov/show/NCT03721588 Completed Bozyaka Training and Research Hospital 2017-06-01
NCT03719950 Study on the Quality of Life Among Adolescents With Attention Deficit/Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT03719950 Completed Centre Psychothérapique de Nancy 2019-12-31
NCT03523663 System for Determining Ideal Drug Doses for ADHD - Stages 1 and 2 https://ClinicalTrials.gov/show/NCT03523663 Recruiting University of Wisconsin, Madison 2020-12-31
NCT03441009 Metabolism and the Activity of the Autonomic Nervous System in Patients With Paroxystic Sympathetic Hyperactivity, PSH https://ClinicalTrials.gov/show/NCT03441009 Active, not recruiting Region MidtJylland Denmark 2020-10-01
NCT01108354 The Serotonin Transporter in Attention Deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT01108354 Completed Medical University of Vienna 2013-04-30
NCT00966394 Salivary Bacteria and Oral Health Status in Children With ADHD https://ClinicalTrials.gov/show/NCT00966394 Completed Hadassah Medical Organization 2010-05-31
NCT00885807 A Prospective Chart Review to Validate the WFIRS (Weiss Functional Impairment Rating Scale) https://ClinicalTrials.gov/show/NCT00885807 Completed University of British Columbia 2011-04-30
NCT00879320 Healthy Lifestyle in Adults With Attention Deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT00879320 Completed Massachusetts General Hospital 2012-05-31
NCT04326543 Temperament Dimensions and Awakening Salivary Cortisol Levels in ADHD. https://ClinicalTrials.gov/show/NCT04326543 Completed Università degli Studi di Sassari 2017-09-29
NCT02290899 Modulation of Behavioral Inhibition in Attention Deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT02290899 Completed Rhode Island Hospital 2017-08-07
NCT02281825 Correlating Real and Virtual World Behavioral Fluctuations in Adolescence https://ClinicalTrials.gov/show/NCT02281825 Completed Shalvata Mental Health Center 2015-12-31
NCT00916071 Association Between Attention Deficit Hyperactivity Disorder and Bulimia Nervosa in Outpatients With Eating Disorders https://ClinicalTrials.gov/show/NCT00916071 Completed Massachusetts General Hospital 2010-02-28
NCT00776737 Studies of Measures of Attention https://ClinicalTrials.gov/show/NCT00776737 Completed National Institutes of Health Clinical Center (CC) NA
NCT00745524 Screening for Attention-deficit/Hyperactivity Disorder (ADHD) in Adolescent and Adult High Risk Populations https://ClinicalTrials.gov/show/NCT00745524 Completed National Taiwan University Hospital NA
NCT00711724 Comparison of Self and Clinician Administered Rating Scales in Patients With ADHD https://ClinicalTrials.gov/show/NCT00711724 Completed Massachusetts General Hospital 2009-03-31
NCT00646464 New Continuous Performance Tests (CPT) for the Diagnosis of Pediatric Attention Deficit/Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00646464 Completed Hadassah Medical Organization 2010-05-31
NCT00598182 Adherence and Long-term Effect of OROS Methylphenidate (CONCERTA): A Follow-up Study https://ClinicalTrials.gov/show/NCT00598182 Completed National Taiwan University Hospital NA
NCT00595751 NeuroLex EEG-Based ADHD Assessment Aid, Pivotal Study https://ClinicalTrials.gov/show/NCT00595751 Completed Lexicor Medical Technology, LLC 2008-06-30
NCT00508677 Mazindol in Children With ADHD : Open-label, Efficacy, Safety and Pharmacokinetic Pilot Trial https://ClinicalTrials.gov/show/NCT00508677 Completed Assistance Publique - Hôpitaux de Paris 2009-07-31
NCT00491647 Time Perception Deficits and Attention-Deficit/Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT00491647 Completed National Taiwan University Hospital NA
NCT00460720 Compliance Survey of ADHD Medication for Optimal Satisfaction (COSMOS) https://ClinicalTrials.gov/show/NCT00460720 Completed Johnson & Johnson Taiwan Ltd NA
NCT00434928 Dietary Intake and Nutrient Status of Children With ADHD https://ClinicalTrials.gov/show/NCT00434928 Completed University of British Columbia NA
NCT00417781 A Follow-up, Family Study on Attention-deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT00417781 Completed National Taiwan University Hospital NA
NCT00416091 Neuropsychological Functioning Among Children With Tourret’s Disorder and ADHD https://ClinicalTrials.gov/show/NCT00416091 Completed National Taiwan University Hospital NA
NCT00397748 PET Scanning of Adults With Attention Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00397748 Completed National Institutes of Health Clinical Center (CC) NA
NCT00341029 Genetic Measurements in Blood Cells of Children Taking Adderall or Methylphenidate https://ClinicalTrials.gov/show/NCT00341029 Completed National Institutes of Health Clinical Center (CC) 2007-09-30
NCT00328224 Oral Status and Prevalence of Dental Trauma in Children Treated With Ritalin Due to Attention-Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00328224 Completed Hadassah Medical Organization NA
NCT00181857 Risk of Attention Deficit Hyperactivity Disorder (ADHD) in the Children of Adults With ADHD Not Otherwise Specified (NOS) https://ClinicalTrials.gov/show/NCT00181857 Completed Massachusetts General Hospital 2006-02-28
NCT00161161 Genetic Liability in the Brain Morphology of Attention Deficit Hyperactivity Disorder https://ClinicalTrials.gov/show/NCT00161161 Completed UMC Utrecht NA
NCT00104039 Brain Changes in Children and Adolescents With Behavioral Problems https://ClinicalTrials.gov/show/NCT00104039 Completed National Institutes of Health Clinical Center (CC) NA
NCT00051337 Single Photon Emission Computed Tomography (SPECT) to Study Paroxysmal Hyperkinetic Movement Disorders https://ClinicalTrials.gov/show/NCT00051337 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001497 Assessment of Attentional Functioning in Children With HIV-1 Infection https://ClinicalTrials.gov/show/NCT00001497 Completed National Institutes of Health Clinical Center (CC) NA
NCT00026546 Behavior in Children With Attention Deficit Hyperactivity Disorder and in Healthy Volunteers https://ClinicalTrials.gov/show/NCT00026546 Completed National Institutes of Health Clinical Center (CC) NA
NCT00008892 Brain Imaging in Children With AD/HD https://ClinicalTrials.gov/show/NCT00008892 Completed National Institutes of Health Clinical Center (CC) NA
NCT00339729 Johnston County ADHD Study: Environmental, Reporductive, and Familial Risk Factors for Attention-Deficit Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00339729 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001206 Biological Markers in Attention Deficit/Hyperactivity Disorder (ADHD) https://ClinicalTrials.gov/show/NCT00001206 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001915 Study of Attention Deficit/Hyperactivity Disorder Using Transcranial Magnetic Stimulation https://ClinicalTrials.gov/show/NCT00001915 Completed National Institutes of Health Clinical Center (CC) NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT02136147 ADHD Medication and Predictors of Treatment Outcome https://ClinicalTrials.gov/show/NCT02136147 Enrolling by invitation Karolinska Institutet 2020-12-31
NCT01793168 Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford https://ClinicalTrials.gov/show/NCT01793168 Recruiting Sanford Health 2100-12-31
NCT03944083 Children With ADHD and Emotional Dysregulation https://ClinicalTrials.gov/show/NCT03944083 Recruiting Oslo University Hospital 2021-08-31